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ABSTRACT
THE CONFORMATIONAL GYMNASTICS OF THE E. COLI SECA MOLECULAR
MACHINE AND ITS INTERACTIONS WITH SIGNAL SEQUENCES
MAY 2009
JENNY LYNN MAKI
B.S., UNIVERSITY OF MINNESOTA DULUTH
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Lila M. Gierasch

Protein secretion is a selective and regulated process that is essential in all
organisms. In bacteria the preprotein translocase SecA, either free in the cytosol or
associated with the SecYEG translocon, recognizes and binds most post-translational
secretory proteins containing an N-terminal signal sequence. In Gram-negative bacteria,
the molecular chaperone SecB binds many of the preproteins to keep them in a
translocation-competent state. Subsequently, SecB delivers the preproteins to the
translocon-associated SecA, which binds the signal sequence and also interacts with
mature regions of the preprotein. After the preprotein/SecA/SecYEG complex has
formed, the energy derived from ATP hydrolysis by SecA coupled with the proton
motive force drives the insertion of the preprotein through the translocon pore. During the
translocation reaction, the conformation of SecA dramatically changes from an inactive
closed form (c-SecA) to one more active and open states. The various crystal structures
of SecA have provided many structural details about c-SecA. The recent low resolution
viii

crystal structure of a fragment of SecA bound to SecYEG (Zimmer et al., 2008) has
provided a starting point for structural analysis of the active and open conformation of
SecA. Previous work in our laboratory demonstrated that an N-terminal proteolytic
fragment of SecA, SecA64, is an activated form of SecA that with higher affinity signal
peptides better than c-SecA (Triplett et al., 2001). To correlate the SecA64 results with
full-length SecA, we determined that SecA in the presence of low concentrations of urea
has an enhanced ATPase activity similar to translocation level, which is comparable to
what was observed with SecA64. Analysis by CD and Trp fluorescence indicates the
presence of an intermediate at 2.2 M urea at 22ºC (termed u-SecA). Using limited
proteolysis, we determined that u-SecA is in an protease-sensitive conformation that
mimics the translocation-active form of SecA. These structural rearrangements occur
primarily in the C-terminal one-third of the protein. Next, we sought to understand the
signal sequence interactions with c-SecA and translocation-active u-SecA. Using a
photoactivatable cross-linking approach along with limited proteolysis, two-dimensional
gels, and domain mapping with region-specific antibodies, the signal sequence-binding
site was mapped to the interface of NBF II, PPXD, and HSD. The site is the same in both
forms of SecA but in our data suggests u-SecA that the binding groove as expanded.
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CHAPTER 1
INTRODUCTION
Portions of this chapter are part of a review paper written in collaboration with Eugenia
M. Clerico and Lila M. Gierasch. (Clerico E.M., Maki, J.L., Gierasch, L.M. Use of
synthetic signal sequences to explore the protein export machinery. Biopolymers (Peptide
Science). 2008, 90 (3): 307-319.)
1.1

General overview of protein secretion
Secretion is a highly selective and regulated process that is essential for the

survival of any organism. In all kingdoms of life, the genes that code for proteins are
translated predominantly by cytosolic ribosomes, yet nascent polypeptide chains are
targeted to a variety of locations throughout the cell. As newly synthesized proteins
emerge from the ribosome, they are greeted by a host of chaperones and targeting factors
that effectively partition the proteins that are cytosolic from those that need to be
translocated across a membrane (Ullers et al., 2007). In general, proteins that are destined
for secretion or integration into a membrane contain a zip code called a signal sequence,
which targets the ribosome nascent chain complex (RNC) or the post-translational
proteins to the secretory apparatus (von Heijne, 1998). These polypeptides bind to
secretory components through specific interactions and are translocated across the
membrane, which is typically the plasma membrane in prokaryotic organisms and the
endoplasmic reticulum (ER) membrane in eukaryotic organisms. In bacteria, secretory
proteins are either translocated across another membrane such as the outer membrane or
are folded into their final native state in the periplasm. In eukaryotes secretory proteins
are correctly folded in the ER and ultimately trafficked to their final destination such as
the plasma membrane or an organelle (Clerico et al., 2008).

1

1.2

Signal sequences
The targeting of nascent polypeptides to their final non-cytoplasmic destination is

a crucial process in both prokaryotic and eukaryotic organisms. The targeting of these
proteins is usually mediated by an N-terminal signal sequence, which directs the posttranslational protein or the RNC to the inner membrane in prokaryotes and the
endoplasmic reticulum in eukaryotes (Figure 1.1) (Schnell and Hebert, 2003). Despite
their universal functions in all realms of life, signal sequences lack primary sequence
homology, even in proteins that are closely related. Although without primary structure
homology, signal sequences share a common distribution of residue types and are
typically 15 to 30 residues in length (Figure 1.2, A). The N-terminus portion of the signal
sequence, the so-called n-region, has an overall positive charge and is variable in length
(Gierasch, 1989). It has been suggested that the requirement for the positive charge at the
N-terminus can be compensated by the addition of a longer hydrophobic core (Hikita and
Mizushima, 1992). The middle part of a signal sequence called the h-region, is enriched
several Leu, Ala, Met, Val, Ile, or Phe residues and therefore, is highly hydrophobic. This
hydrophobic region is the hallmark of a signal sequence and consists of 7 to 13 residues.
The hydrophobic segment is shorter than a membrane spanning helix but is longer than a
typical hydrophobic segment found in globular proteins (von Heijne, 1985). The third
region of the signal sequence, the c-region, is uncharged, polar, and contains the signal
peptidase cleavage site, A-X-A where X is any amino acid (Gierasch, 1989). The signal
sequence is typically cleaved during the translocation of the preprotein (von Heijne,
1990). These general features of signal sequences have likely been evolutionarily

2

Figure 1.1 The Sec secretion pathways
Secretory and integral membrane proteins are targeted to the endoplasmic reticulum (ER)
membrane in eukaryotes and the plasma membrane in prokaryotes. SRP-mediated
translocation: The membrane protein (pink) emerges from the ribosome (gray) and SRP
(light blue) recognizes and binds the signal sequence (red). The nascent chain complex
(RNC) and SRP are targeted to SRP receptor (dark blue) at the membrane. Further
translation of the protein is arrested or retarded at this step in eukaryotes and the nascent
chain is maintained in an unfolded conformation needed for translocation. The interaction
between the SRP and the SRP receptor delivers the RNC to the Sec translocon (green)
and the nascent protein crosses or is inserted into the membrane. SRP is released from it
receptor to start another targeting cycle. SecA-mediated targeting: After translation by the
ribosome, the mature regions of the secretory protein interact with the molecular
chaperone SecB (orange) to prevent protein folding. Through signal sequence
recognition, the SecB-preprotein complex associates with SecA (purple), which is either
in the cytosol or associated with the plasma membrane. This complex binds to the
SecYEG translocon and induces the release of SecB. SecA undergoes conformational
gymnastics to facilitate preprotein translocation across the inner membrane. Adapted
from Clerico et al. (Clerico et al., 2008).
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optimized for the particular passenger protein and the role of the passenger protein in the
cell (Gierasch, 1989).
Genetic studies in E. coli have demonstrated that defects in signal sequences can
be compensated by suppressor mutations in another part of the signal sequence. Early
genetic work on secretory proteins in E. coli performed by Emr and Silhavy (Emr and
Silhavy, 1980) demonstrated that most point mutations in the signal sequence did not
inhibit translocation but some drastic point mutations could block export. Many of the
mutations that change translocation of a preprotein occur in the hydrophobic core. For
example, if a residue in the h-region of the λ phage receptor (LamB) signal sequence was
mutated to a negative residue export was inhibited. Export of LamB can be inhibited by
the deletion of four residues from the h-region. The fact that the inhibition can be
reversed by mutation of either Pro9 to Leu or Gly17 to Cys (Figure 1.2, B) (Emr and
Silhavy, 1980). The importance of both the n- and h-regions has also been assessed using
the alkaline phosphatase signal sequence. Mutant signal sequences with a negative charge
at the N-terminus and a highly hydrophobic h-region can be secreted rapidly but a less
hydrophobic h-region cannot be exported. Therefore, the n- and h-regions are both
involved in for recognition by the transport machinery (Izard et al., 1996). These results
demonstrated that the primary structure is not critical for targeting by the signal sequence
but the positive n-region and even more so the hydrophobic core are very important in the
correct targeting of preproteins (Gierasch, 1989).
Even though signal sequences lack primary sequence homology, they are
interchangeable between proteins even among vastly different organisms. Proteins
carrying signal sequences from a prokaryotic protein can be secreted in a eukaryotic cell

5

Figure 1.2 General features of signal sequences
A. The three regions of a signal peptide. Adapted from Chou. (Chou, 2003). B. The E.
coli λ-receptor (LamB) series of signal sequences. The relative position from the start of
the signal sequence is indicated by the numerals above the amino acid sequence. Deleted
amino acids are denoted by the dash, inserted amino acids are indicated by bold letters,
the position of amino acid substitutions are shown by single letters. Adapted from Triplett
et al. (Triplett et al., 2001).
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and vice versa (Muller et al., 1982; Talmadge et al., 1980).This ability of signal
sequences from different organisms to still direct protein secretion implies that the
recognition mechanisms of secretory machinery have not changed greatly during
evolution (Briggs and Gierasch, 1986).
Recent studies in mammalian cells have shown that signal sequences likely have a
role in the efficiency of preprotein translocation. One example of this is the cell surface
glycoprotein, prion protein (PrP). Incorrect targeting of this protein to the ER is caused
by a slight inefficiency of the PrP signal sequence. This inefficiency leads to the
generation and build-up of both a cytosolic form and an incorrect topologic form of PrP,
leading to neurodegeneration (Hegde and Bernstein, 2006). If the PrP signal sequence is
replaced with a more efficient signal sequence such as the one from prolactin, there is an
increase in the amount of PrP in the correct topological form (Ott and Lingappa, 2004).
These results suggest that signal sequences not only act as targeting sequences but also
affect the efficiency of translocation.
Genetic work in a mutant E. coli strain demonstrated that the removal of four
hydrophobic residues from the h-region of the LamB signal sequence caused a defect in
export (Emr and Silhavy, 1983). In two pseudorevertant strains, LamB was successfully
exported and genetic examination of these strains demonstrated that each had a secondary
point mutation within the signal sequence. In one case, the Gly17 was replaced by Cys,
LamBΔ78r1. In the other case, the Pro9 was replaced by Leu, LamBΔ78r2 (Figure 1.2,
B). Therefore, the loss of four hydrophobic residues was somehow compensated by
single residue changes. Since both Gly and Pro can act as helix breakers, it was proposed
that the signal sequence must adopt α-helical conformation to function.

8

Our group tested the secondary structure hypothesis by using synthetic signal
peptides in solution as well as in phospholipids monolayers and vesicles (Gierasch et al.,
1985). In solution the LamB signal peptide adopted a largely random conformation as
monitored by far-ultraviolet (UV) circular dichroism (CD) analysis. In the presence of
polyfluorinated alcohols, which can mimic the membrane interior, the signal peptide
become partially helical (Briggs and Gierasch, 1986). This work was extended further to
examine the deletion and pseudorevertants mutants discovered by Emr and Silhavy (Emr
and Silhavy, 1983). The deletion mutant remained predominately in a random coil
conformation in buffer, sodium dodecyl sulfate (SDS) micelles, trifluoroethanol, and
phospholipid vesicles. The wild type LamB signal peptide as well as the two
pseudorevertants had random coil conformations in buffer but adopted a much more
helical structure in the presence of an apolar environment (Briggs and Gierasch, 1986).
These results are consistent with the hypothesis that signal sequences must adopt an αhelical structure for function.
Further studies showed that some non-functional signal sequences adopt α-helical
structures in apolar environments meaning that the structural conformation itself is not
sufficient for signal sequence function (McKnight et al., 1989). Therefore, our group used
surface tensiometry experiments using phospholipids monomers to assess the interactions
of signal peptides with phospholipids monolayers. The functional LamB signal peptides
were able to insert into the monolayer but the non-functional signal peptides were only
able to interact with the phospholipids head groups of the lipids. The non-functional
signal peptides that can adopt α-helical conformation could only insert into the
monolayers at high peptide concentrations (Briggs et al., 1985; McKnight et al., 1989).

9

The same biophysical characteristics of the LamB signal peptide are observed in other
functional and non-functional synthetic signal peptides such as the outer membrane
protein OmpA (Hoyt and Gierasch, 1991a; Hoyt and Gierasch, 1991b; Rizo et al., 1993).
At least in the case of the LamB signal sequence, the adjacent mature region of the
preprotein does not affect the secondary structure or the membrane-binding properties of
the signal sequence (McKnight et al., 1991). This implies that functional signal sequences
not only need to be able to adopt an α-helical conformation but also need to be able to
insert into the phospholipids membrane.
In spite of their diversity and lack of primary sequence homology, signal
sequences have very distinct features and properties that specifically direct preproteins to
the secretory apparatus. Signal sequences are interchangeable between species and are
tolerant of many mutations. Recently, it has come to light that signal sequences are not
just simple interchangeable domains that serve as simple targeting motifs but have
specific properties that have been optimized for the proper biosynthesis of its substrate
protein (Hegde and Bernstein, 2006).

1.3.

Protein translation and chaperones
All proteins are synthesized by the decoding of the messenger ribonucleic acids

(mRNA) by the ribosome. In E. coli the ribosome is made of 55 components and is
formed by two subunits, 30S and 50S, which together form the 70S particle. This 70S
ribosome consists of about two-thirds ribosomal RNA (rRNA) and one-third protein. The
larger 50S subunit is made from two rRNAs, the 23S and the 5S, and 33 proteins. The
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smaller 30S subunit is composed of the 16S rRNA and 21 ribosomal proteins
(Kaczanowska and Ryden-Aulin, 2007).
The translation process can be broken down into three stages: initiation,
elongation, and termination, and the initiation stage is thought to be the rate limiting in
the translation process. The messenger RNA (mRNA) is recognized by the 30S subunit
and initiation factors aid in the recognition of the Shine-Dalgrano sequence in the mRNA.
This allows for the proper orientation of the start codon and then the 50S subunit
assembles forming the 70S particle. During elongation aminoacylated transfer RNA
(tRNA) corresponding to the codon in the mRNA binds the ribosome at the A site. The
aminoacyl group is released by the elongation factor EF-Tu and the tRNA is moved into
the P site. Another aminoaceylated tRNA corresponding to the next codon in the mRNA
binds to the free A site. This positions the tRNAs so that peptide bond formation occurs.
The deacylated tRNA is then repositioned from the P site to the E site and is eventually
pushed into the exit tunnel of the ribosome. When a stop codon enters the A site, release
factors bind and induce release of the peptide chain from the P site (Kaczanowska and
Ryden-Aulin, 2007).
As nascent polypeptide chains emerge from the bacterial ribosome, they are
greeted by two ribosome-bound chaperones, the signal recognition particle (SRP) and
trigger factor (TF), and both bind the polypeptide chain co-translationally (Hoffmann et
al., 2006). Proteins lacking signal sequences are recognized by TF, which can deliver the
protein to another chaperone system such as GroEL (Kandror et al., 1995) or Hsp70 to
assist in proper folding (Deuerling et al., 1999). Proteins containing signal sequences
with long hydrophobic cores and transmembrane segments interact specifically with SRP
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while TF binds less hydrophobic signal sequences to prevent SRP binding allowing for
targeting the SecA post-translationally (Beck et al., 2000). A more in-depth description of
SRP and SecA is presented in section 1.6.1. and 1.7., respectively. TF binds to stretches
of eight amino acids that are enriched with basic and aromatic amino acids. The binding
motif of TF is similar to the binding motif of another molecular chaperone, DnaK. Since
these chaperones share a similar binding motif but are in different locations in the cell,
they may be able to cooperate in protein folding (Deuerling and Bukau, 2004). The
structure of TF revealed an unusual extended conformation that is made up of three
domains (Figure 1.3, A). The ribosome-docking region is found in the N-terminal domain
while the peptidyl-prolyl isomerase domain is at the other end of the structure. The Cdomain is sandwiched between the other two domains and forms the “arms” of TF
(Hoffmann et al., 2006). When bound to the ribosome, TF is hunched over the
polypeptide exit tunnel, which shields the nascent polypeptide and allows for TF to
capture the chain in its hydrophobic cradle (Figure 1.3, B). The binding of TF may delay
folding to allow for more of the chain to emerge from the ribosome so that the correct
amount of sequence is present for folding (Deuerling and Bukau, 2004).
In E. coli and many other Gram-negative bacteria, there is a dedicated secretion
chaperone called SecB. There are several other molecular chaperones in bacteria such as
GroEL, DnaJ, and DnaK but it is still unclear if these chaperones have any role in protein
secretion. SecB can rapidly bind nascent chains still attached to the ribosome or to
partially folded preproteins in the cytosol (van Wely et al., 2001). SecB associates and
dissociates with polypeptide substrates without the use of ATP, which is in contrast to
other chaperone such as GroEL and DnaK (Danese and Silhavy, 1998). The structural
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Figure 1.3 Structure and function of trigger factor
A. Crystal structure (1W26) of soluble trigger factor color-coded for the different
domains: red, the N-terminal ribosome-docking region, yellow, the peptidyl-prolyl
isomerase domain, and green, the C-terminal domain. B. Schematic representation of
trigger factor bound at the exit tunnel of the ribosome. Adapted from Hoffmann et al.
(Hoffmann et al., 2006).
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organization of SecB is a homotetramer that is a dimer of dimers. There is a long channel
located on both sides of the tetramer that is proposed to be involved in the binding of the
polypeptide chain. This groove has two subsites with one deep cleft lined with aromatic
residues and one shallow groove, which is hydrophobic in nature. The orientation of the
two grooves allows the polypeptide to wrap around the SecB tetramer. The basis for how
SecB differentiates between cytosolic and secretory proteins is still unclear since the
binding motif is about nine amino acid in length and enriched in both aromatic and basic
residues, which is very similar to other molecular chaperones. SecB keeps the preprotein
in an unfolded state for translocation and targets the complex to the preprotein
translocase SecA (Driessen and Nouwen, 2008).

1.4.

Secretory pathways in prokaryotes
The secretion of proteins in bacteria is an intricate dance that requires specific

recognition and delivery of the correct substrates to the proper translocation machinery.
Bacterial cells have several different types of secretion systems including outer
membrane systems (Saier, 2006). The development of distinct systems for general
secretion, type II represented by the Sec and Tat pathways, enable cell survival while the
more specialized systems, type I, III, and IV, are involved in pathogenesis.

1.4.1. Type I, III, and IV secretion systems
Gram-negative bacteria have developed specialized membrane secretion systems.
The type I, type III, and type IV secretory pathways can export proteins across both the
inner and outer membranes in one energy-coupled step. The type II secretory pathways
cross only the cytoplasmic membrane. The type I ATP-binding cassette (ABC)
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macromolecular system generally consists of two integral membrane domains and two
cytoplasmic domains. This ABC transporter can associate with the main terminal branch
(MTB) and outer membrane factor (OMF) proteins to enable secretion across both
membranes. This system can transport ions, drugs, and proteins of various sizes including
pathogens outside of the cell (Saier, 2006).
Gram-negative pathogens have also developed two direct transport systems for
the delivery of virulent proteins into the host organism to establish infection. The type III
pathway assembles a needle complex and shares common ancestral relationship to the
flagellar secretion system. The needle consists of a basal body structure that is assembled
using the Sec pathway. This structure is followed by the needle filament assembly, which
can interact with the host cell membrane and compromise its integrity. Once the needle
has made contact with the host cell the virulent proteins are secreted into the host cell and
begin to manipulate the host’s cellular processes (Cambronne and Roy, 2006).
The type IV secretion system has some similarities to the type III system but is
ancestrally related to the conjugation systems in bacteria. This secretion system also
delivers into the cytosol of the host cell various virulent proteins, which modify the host
cell’s physiology. The type IV system is made up of multiple subunits that span both the
inner and outer membranes in Gram-negative bacteria. It is composed of a secretion
channel and a surface filament or proteins (Christie et al., 2005). It is still unclear how the
type IV system compromises the host cell membrane but it is likely that a small conduit
could support the transport of the unfolded substrates (Cambronne and Roy, 2006).
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1.4.2. Type II secretion systems
1.4.2.1.Bacterial Sec pathway
The general secretory (Sec) pathway is one of the main secretory pathways in
prokaryotes (Gierasch, 1989). Signal sequences target proteins to this pathway by binding
either co-translationally to the signal recognition particle (SRP) or post-translationally to
SecA (Vrontou and Economou, 2004). Both of these pathways consist of four steps:
recognizing the preprotein, maintaining the unfolded state, targeting to the translocon,
and translocating across the membrane (Figure 1.1) (Clerico et al., 2008). The Sec
pathway translocates proteins in the unfolded state, thus, allowing for protein insertion
into the cytoplasmic membrane, folding in the periplasmic space, and secretion across or
integration into the outer membrane. The majority of the components of the Sec system
were identified by genetic studies in E. coli and this system contains three major
components: a protein targeting unit, a motor protein, and a membrane embedded protein
channel (Natale et al., 2008). In the SRP pathway, the signal sequence is recognized cotranslationally by SRP and the RNC complex is targeted to the SRP receptor (SR). The
SRP/SR interaction delivers the RNC complex to the SecYEG translocon and continued
translation of the polypeptide pushes it through the translocon. SecA, on the other hand,
recognizes the signal sequence of the preprotein post-translationally. The molecular
chaperone SecB keeps the preprotein in an unfolded conformation and brings it to SecA.
SecA docks at the translocon and uses the energy generated from ATP hydrolysis to push
the preprotein across the SecYEG translocon (Figure 1.1) (Clerico et al., 2008). In
bacteria, the Sec pathway is responsible for the secretion of a majority of the extracellular
proteins, which have a variety of functions needed for cell survival (Natale et al., 2008).
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1.4.2.2.Tat pathway
Another major secretory pathway in bacteria is the Twin-arginine translocation
pathway, often referred to as the Tat pathway (Natale et al., 2008). The biggest difference
between the Sec and the Tat pathways is that the Tat-pathway translocates properly
folded secretory proteins across the cytoplasmic membrane (Figure 1.4, A). The secretory
proteins are targeted to the Tat pathway by N-terminal signal sequences that are similar to
Sec signal sequences. Tat signal sequence are composed of both n- and h-regions and in
some cases a c-region that is cleavable. The recognition element of a Tat signal sequence
is the almost invariant twin-arginine motif at the n-and h-region interface. In general the
motif pattern is Z-R-R-x-φ−φ where Z is any polar residue and φ is any hydrophobic
residue. Additionally, a Tat signal sequence often contains a positive residue in the cregion to ensure that the substrate does not target to the Sec pathway. Many of the Tat
substrates have cofactors added before translocation. Therefore, the Tat system is utilized
to translocate proteins of redox pathways, anaerobic respiration, and the global nitrogen
cycle (Natale et al., 2008) as well as for the establishment of infections in both plants and
animals (Lee et al., 2006). Some Tat substrates do not contain cofactors and may have
specific folding reasons for utilizing this pathway. The Tat translocase consists of TatA
and TatC or TatA, TatB, and TatC, which are all integrated membrane proteins (Natale et
al., 2008). Protein that are transported by the Tat pathway are involved in several cellular
functions that are essential to the survival of the cell (Lee et al., 2006).
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Figure 1.4 The Tat and YidC secretion pathways
A. Model of the targeting and transport in the Tat pathway. Embedded in the membrane
is the SecYEG translocon in green, TatA in red, TatB in blue, and TatC in yellow. (1)
The nascent polypeptide chain emerging from the ribosome avoids targeting to the Sec
pathway by the presence of the twin Arg (RR) residues. (2) The preprotein folds into the
its final conformation and associates with any needed cofactors and/or additional subunits
before targeting to the TatBC receptor complex (3). (4) The formation of the complete
translocase is driven by the proton motive force. The folded preprotein is transported
through the pore, which is formed predominately by TatA. (5) The signal sequence is
removed and the mature protein is released into the periplasm. Adapted from Lee et al.
(Lee et al., 2006). B. Model for YidC interaction with TM segments. The transmembrane
(TM) segment of the protein leaves the SecYEG channel and associates with YidC. The
first TM helix is released into the lipid membrane and the next TM segment binds YidC.
YidC enables the integration of the TM segments during the translocation process.
Adapted from Xie and Dalbey (Xie and Dalbey, 2008).
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1.4.2.3.YidC
YidC is another translocase that is found in bacteria (Scotti et al., 2000) and
organelles of bacterial origin such as the mitochondria (Hell et al., 2001). This protein
can act as an independent insertase to insert proteins into the cytoplasmic membrane
(Scotti et al., 2000). In addition to its own independent function, YidC can also cooperate
with the Sec pathway machinery to aid in membrane protein insertion (Veenendaal et al.,
2004) The independent function of YidC was discovered by its depletion from the
membrane. Once YidC is no longer present, the insertion of Sec-independent proteins
was inhibited (Samuelson et al., 2000). As an insertase, YidC plays a crucial role with the
F1F0 ATPase (van der Laan et al., 2004) and cytochrome bo3 oxidase (Stenberg et al.,
2007). The role of YidC in these membrane-bound enzymes is likely the insertion of one
of the subunits for the F1F0 ATPase or insertion of part of the enzyme into the membrane
for cytochrome bo3 oxidase (Figure 1.4, B) (Xie and Dalbey, 2008). Recently, a mediumlevel resolution map of YidC was determined by electron cryomicroscopy and revealed
that YidC can form dimers in membranes (Lotz et al., 2008). It was proposed from this
structure that the nature of the dimer interface could indicate the pathway, either Secdependent or Sec-independent, for insertion of membrane proteins. YidC may act as a
monomer in the complex with SecYEG but act as a dimer for independent insertion of
proteins.
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1.5.

Secretory pathways in eukaryotes
Although prokaryotes and eukaryotes are very different, they still share a similar

co-translationally preprotein targeting system, SRP but have evolved different posttranslational systems. Organelles of prokaryotic origin have import machinery that is
different from the plasma membrane export machinery in prokaryotes indicating that
these organelles have evolved their translocation machinery.

1.5.1. Eukaryotic Sec pathway
In eukaryotic cells, protein secretion and membrane integration of proteins is
more complicated than in bacteria due to the presence of membrane-bound organelles
such as: nucleus, endoplasmic reticulum (ER), golgi apparatus, lysosome, endosome,
peroxisome, mitochondria, and chloroplast. Most of the polypeptides are initially targeted
to the ER for modification and folding before being sorted to their final destination
(Alder and Johnson, 2004). The preprotein must translocate across the ER membrane
from the cytosol where it was translated by the ribosome. In co-translational
translocation, the RNC complex is recognized by the SRP and is similar to the system
found in prokaryotes. The SRP/RNC complex is targeted to the SRP receptor (SR) at the
ER membrane. This directs an interaction between the ribosome and the Sec61 translocon
embedded in the ER membrane. The elongating nascent polypeptide chain associates
with the translocon and the continued translation of the polypeptide translocates the
preprotein through the channel (Figure 1.1) (Rapoport, 2008).
Another subset of proteins is translocated post-translationally in eukaryotes but
this is different from the bacterial SecA system. This post-translational translocation
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involves the Sec61 translocon associating with the Sec62/63 protein complex. Initial
recognition of the preprotein is mediated by Sec62/63, which subsequently transfers the
preprotein to Sec61 (Schnell and Hebert, 2003). The translocation of the preprotein, at
least in yeast, occurs through a ratcheting mechanism by interactions between the
preprotein, Sec62/63, and BiP, an ER luminal Hsp70 chaperone. After a transient
interaction with Sec63, BiP hydrolyzes ATP and closes its peptide-binding pocket on the
translocation substrate. This prevents any backward sliding into the cytosol by the
preprotein and enables forward movement into the ER lumen. After additional segments
of preprotein enter the ER, another BiP molecule binds and the process is repeated until
the entire preprotein has been translocated. Once ADP is exchanged for ATP, the BiP
molecule is released from the translocated substrate (Rapoport, 2008).

1.5.2. Protein import into mitochondria and chloroplasts
Both mitochondria and chloroplast contain multiple membranes, which likely
arose from an endosymbiotic relationship with prokaryotes. During the evolution, almost
all of the genes from the endosymbiotic prokaryote were transferred to the nucleus of the
host cell (von Braun and Schleiff, 2007). As a consequence N-terminal presequences or
transit peptides are needed to target these proteins back to the correct organelle.
Therefore, mitochondria and chloroplasts possess numerous translocons to translocate
preproteins to the outer membrane, inner membrane, intermembrane space, and the
internal soluble compartments (Schnell and Hebert, 2003).
The presequence of a mitochondrial protein directs it to the translocon of the
mitochondrial outer membrane (TOM) (Figure 1.5, A). Tom20 and Tom22 act as the
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receptor domains while Tom40 forms the channel. Tom40 is not only a channel but also
recognizes the preproteins and aids in the sorting of preproteins to the correct
compartment. The TOM complex is used for the import of all preproteins across the outer
membrane (Kutik et al., 2007). Preproteins destined for the mitochondrial matrix or inner
membrane are directed to the translocon of the mitochondrial inner membrane (TIM).
There are two TIM translocons in mitochondria. One, Tim23, is predominately
responsible for the translocation of matrix proteins and a subset of integral membrane
proteins containing a single membrane-spanning domain (Schnell and Hebert, 2003).
This translocation process needs the assistance of the presequence translocase-associated
motor (PAM). Small proteins destined for the intermembrane space (IMS) are imported
into the IMS by the mitochondrial intermembrane space assembly machinery (MIA). The
outer membrane β-barrel preproteins are imported by TOM and transferred by
chaperones to the sorting and assembly machinery (SAM). The proteins of the inner
membrane translocate through TOM and are transferred to the other mitochondrial
translocon, Tim22, for insertion into the membrane (Kutik et al., 2007).
The translocon of the outer membrane of the chloroplast (TOC) has three core
components, Toc159, Toc34, and Toc75 (Figure 1.5, B). Toc159 and Toc34 are GTPbinding proteins located at the chloroplast surface and interact with the preprotein at the
beginning of the import process while Toc75, which likely forms a β-barrel structure,
constitutes the channel protein. Toc 159 is the primary receptor for preproteins and works
with Toc75 to translocate preproteins across the chloroplast outer membrane. Most of the
outer membrane proteins actually lack a transit peptide and are targeted by signals within
their membrane anchor. Preprotein transport across the outer membrane requires both
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Figure 1.5 Protein import pathways in mitochondria and chloroplast
A. Most mitochondrial proteins are synthesized in the cytosol by ribosomes and imported
through the TOM complex. Matrix proteins containing presequences are transported by
the TIM23 complex in conjunction with the motor protein PAM into the matrix. The
mitochondrial processing peptidase (MPP) removes the presequence. The IMS small
proteins are imported using the mitochondrial intermembrane space assembly machinery
(MIA). Outer membrane (OM) precursors are transferred from TOM to SAM by Tim9Tim10 chaperone. Inner membrane (IM) precursors are transferred to the TIM22 complex
by Tim9-Tim10. TIM22 drives the insertion of these IM proteins into the inner
membrane. Figure adapted from Kutik et al. (Kutik et al., 2007). B. Core components of
the chloroplast import pathway are shown in color. After translation by the ribosomes,
preproteins are transported across the TOC complex, which consists of Toc159 and
Toc34 as the receptors and Toc75 as the channel. Some preproteins are guided to the
TOC complex by 14-3-3 protein and a Hsp70 chaperone. After translocation across the
outer membrane, the preproteins interact with Hsp70 in the intermembrane space, which
guides the preprotein to the TIC complex with assistance from Tic22. The TOC and TIC
complexes associate and the preprotein crosses both membranes. The channel has been
proposed to be formed by Tic110 and Tic20. The chaperones Cpn60 and Hsp93 help
Tic40 fold the imported proteins. The transit peptide is cleaved from the preprotein by the
stromal processing peptidase (SPP). Figure adapted from Kessler and Schnell (Kessler
and Schnell, 2006).
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ATP and GTP. Therefore, a Hsp70 has been proposed to function as the driving force for
translocation while the Toc GTPases act as the regulators and receptors during initiation
of translocation. The inner membrane translocon complex, the Tic components, has not
been isolated in stoichiometric amounts. The Toc and Tic components begin to physically
interact with each other during the early stages of translocation. This suggests that the
inner membrane translocon is assembled in response to early interactions with Toc
translocon. Two proteins form the proposed channel components for the inner membrane
translocon, Tic110 and Tic20. It has been suggested that Tic110 is the docking site for
the preproteins while Tic20 likely forms the membrane channel and is distantly related to
channels of the mitochondrial inner membrane. Tic110 also associates with the molecular
chaperones in the stroma and these chaperones provide the driving force the preprotein
translocation across the inner membrane (Kessler and Schnell, 2006).

1.6. Protein targeting and translocation in bacteria
1.6.1. SRP
The signal recognition particle is a ribonucleoprotein, which is found in all three
kingdoms of life. SRP was first identified in mammalian cells and later in prokaryotic
cells. The E. coli SRP is one of the simplest of the SRPs because it consists of only one
protein, called Ffh for fifty-four homolog due to its homology to the mammalian SRP54
protein, and a 4.5S RNA (Luirink et al., 2005). The Ffh component of the E. coli SRP is
responsible for the binding of signal sequences. Ffh is made of three domains, the N
domain, which interacts with the ribosome, the G domain, which has a GTP binding site
and is also involved in binding SR, and the M domain, which has a high Met content and
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interacts with the RNA (Clerico et al., 2008). The signal sequence likely binds to the M
domain but also shows interaction with the NG domain (Cleverley and Gierasch, 2002).
Unlike its mammalian counterparts, which target both secretory, and membrane proteins
to the ER, E. coli SRP is predominantly involved with the translocation of inner
membrane proteins. SRP actually interacts with the ribosome near the exit tunnel and
binds to the signal sequences of integral membrane proteins (Figure 1.1). The SRP targets
the RNC complex to the SR in the plasma membrane. The interaction between SRP and
SR mutually stimulates each other’s GTPase activity and the RNC complex is transferred
to the adjacent SecYEG translocon. The GDP-bound SRP is released from the complex
so it can start another cycle (Clerico et al., 2008).

1.6.2. SecA
SecA is a preprotein translocase found primarily in bacteria but is also found in
organelles of prokaryotic origin such as the chloroplast. Not only do bacterial SecA
recognize and many different secretory proteins but it also acts as a processive motor to
translocate preproteins across the inner membrane (Clerico et al., 2008). After translation
and release from the ribosome, secretory proteins are held in the unfolded state by the
molecular chaperone SecB. This new complex of the preprotein/SecB is targeted to SecA
either in the cytosol or at the membrane. SecA recognizes and binds the signal sequence,
a mature region of the preprotein, and SecB. SecA also interacts with both the SecYEG
translocon through specific interactions with SecY and the inner membrane. These
interactions induce a dramatic conformational change in SecA, which results in the
release of the chaperone SecB. Using the energy from ATP hydrolysis as well as the
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proton motive force, SecA undergoes further conformational gymnastics to translocate
the preprotein across the inner membrane through multiple rounds of binding and release
of the mature portions of the preprotein. Once the preprotein has been completely
translocated, SecA is released and can begin another translocation cycle. (Driessen et al.,
2001). A more in-depth description of SecA is presented in section 1.7.

1.6.3. SecYEG Translocon
The bacterial translocon is a heterotrimeric membrane channel composed of three
proteins, SecYEG, while the eukaryotic counterpart to the channel is called Sec61 and is
made from the α, β, and γ subunits. In prokaryotes the largest of the subunits, SecY, is
the core component and has ten transmembrane regions (TM1-TM10), six cytoplasmic
regions (C1-C6), and five periplasmic/luminal loops (P1-P5). SecE is a small membrane
protein and has three transmembrane domains in which only one makes extensive
contacts with SecY. SecG has two transmembrane domains (Collinson, 2005). The first
crystal structure of the channel was solved at 3.2 Å and represents the closed channel.
This SecYEβ structure was from the archaeabacterium Methanococcus jannaschii and
showed that SecY has two domains TM1-TM5 and TM6-TM10 that have an inverted
pseudo-symmetry (Figure 1.6) (Van den Berg et al., 2004). This structure suggests that
one copy of SecY forms the channel pore and this is supported by mutations that
compensate for defective signal mapping to the center of the SecY complex. The central
pore is blocked on the extracytoplasmic side by the presence of a small helix called the
plug, which is part of SecY transmembrane helix 2. In order for substrates to translocate
across the membrane the plug is required to move out of the way. The shape of the
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Figure 1.6 The SecYEG translocon
A. Side view of the SecY complex. The plug shown in green from helix 2a is held in the
‘plug-hole’ in the closed complex. Adapted from Collinson (Collinson, 2005). B. The
crystal structure of M. jannaschii SecY complex (1RH5) seen from the cytoplasm. The
plug shown in green blocks the pore in the closed conformation. Transmembrane (TM) 15 are in blue and TM 6-10 are in red. The bright blue helix is TM2b and SecE and Secβ
are shown in gray. Adapted from Osborne et al. (Osborne et al., 2005).
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channel is a hourglass lined with hydrophilic residues on both sides of the constriction
point while at the point of constriction is several hydrophobic residues. This would
provide a seal so that ions and other small molecules could not diffuse across the
membrane during protein translocation. The pore must also widen to enable the passage
of an unfolded polypeptide chain (Osborne et al., 2005).
In another study using single particle cryo-electron microscopy, the structure of a
translocating ribosome bound to SecYEG was solved and contained two SecYEG
complexes. In this structure, only structural features of 10 Å were observed. The
orientation of the two SecYEG complexes was front-to-front where the lateral gates from
the protomers face each other but do not form a larger channel (Mitra et al., 2005).
Several lines of evidence suggest that SecYEG can exist in different oligomeric states but
this oligomerization does not appear to significantly change the conformation of the
heterotrimer. Another possibility is that translocation partners, such as SecA and the
ribosomes, could modulate the oligomeric state of SecYEG (Rusch and Kendall, 2007).
Recently, two new crystal structures of the translocon were solved (Tsukazaki et
al., 2008; Zimmer et al., 2008). SecYE from Thermus thermophilus bound to an antiSecY Fab fragment was resolved to 3.2 Å resolution (Tsukazaki et al., 2008). Overall,
this structural architecture was similar to the original M. jannaschii SecYEβ structure
(Van den Berg et al., 2004) but the TM6-TM10 region has been altered creating a small
opening and has been termed the ‘pre-open’ state. In a low-resolution structure of SecYE
without the Fab fragment, the structure was similar to the closed form like the SecYEβ
structure. The anti-SecY Fab fragment binds to a motif in C5 that is the same region
where SecA has been demonstrated to bind. These structures suggest that the closed form
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of SecYE is energetically favored when no interacting components are present but the
‘pre-open’ form is a conformation state induced by the binding of a ligand such as SecA
(Tsukazaki et al., 2008).
The second crystal structure solved was of Thermotoga maritima SecYEG bound
to Thermotoga maritima SecA, without its carboxyl-terminal domain. This four-protein
structure was fitted to a 4.5 Å model. The N-terminal residues of SecY, SecE, and SecG,
C-terminal residues of SecY and SecG, as well as the periplasmic loop between TM1 and
TM2a of SecY were not resolved. The SecA-SecYEG complex was strongest in the
presence of ADP-BeFx AlFx, which mimics the intermediate states during ATP hydrolysis
(Zimmer et al., 2008). Both of these structures likely represent the early stages of
preprotein translocation.

1.7. Preprotein translocase SecA
SecA was discovered in the early 1980’s through genetic work. This protein plays
a central role in the bacterial Sec pathway. SecA is only found in prokaryotes and
organelles of prokaryotic origin such as the chloroplast. Like SRP, SecA selectively binds
signal sequences of preproteins but recognizes them post-translationally and most of the
preproteins are destined for the periplasm, the outer membrane, or extracellular secretion.
In addition to signal sequence recognition, SecA also acts as a processive motor to
translocate proteins across the inner membrane (Clerico et al., 2008).
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1.7.1. SecA interaction partners
1.7.1.1.SecA dimerization
SecA is a large protein that interacts with several different ligands during the
preprotein translocation reaction (Figure 1.7). This preprotein translocase is a 102 kD
protein and in solution forms homodimers with a monomer-dimer equilibrium of 0.25 –
0.5 µM depending on protein concentration, salt concentration, temperature, and ligands
(Woodbury et al., 2002). The bacterial cellular concentration of SecA is 5 µM suggesting
that it is mostly in the dimeric form. However, studies have shown that SecA may
function as a monomer during the translocation cycle (Or et al., 2005; Or and Rapoport,
2007; Duong, 2003) while other studies indicate that the SecA dimer stay intact during
translocation (Jilaveanu et al., 2005; de Keyzer et al., 2005; Wang et al., 2008). A recent
crystal structure of SecA bound to the SecYEG translocon indicates that SecA likely acts
as a monomer during the translocation reaction (Zimmer et al., 2008).

1.7.1.2.ATP binding and hydrolysis
SecA is a processive motor enzyme that uses ATP hydrolysis to push preproteins
through the SecYEG channel. Initial studies suggested two distinct ATP binding sites
were available on SecA (Mitchell and Oliver, 1993; van der Wolk et al., 1995; den
Blaauwen et al., 1996; van der Wolk et al., 1997; Miller et al., 2002). The first crystal
structure of SecA showed that only one ATP binding site was present on SecA. The ADP
or ATP binds SecA at the interface between nucleotide binding fold I (NBF I) and
nucleotide binding fold II (NBF II) and stabilizes the SecA molecule in a compact
conformation. The nucleotide binding folds share structural homology with DEAD-box
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Figure 1.7 SecA interacts with several ligands
SecA crystal structure (1M6N) color-coded for the different domains: blue, NBF I;
purple, NBF II; yellow, PPXD; green, HSD; orange, HWD; and red, CTL (see Figure 1.8
more structural details). The nucleotide binding site has been precisely mapped but the
other ligand binding sites are less clear. SecAβ indicates the second SecA protomer.
Adapted from Vrontou and Economou (Vrontou and Economou, 2004).
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helicases. The nucleotide binding site is formed by the helicase motifs. The Walker A
consensus sequence binds the α- and β-phosphates of the nucleotide by forming a P-loop
helix-capping structure. The Walker B consensus sequence is a hydrophobic β-strand
ending in an Asp residue, which contacts the Mg+2 cofactor. The Glu from the DEADbox is the likely candidate for the catalytic base in the ATP hydrolysis reaction (Hunt et
al., 2002).
A subsequent study using NMR, thermodynamic, and biochemical techniques
demonstrated that the regions lining the nucleotide binding cleft undergo transitions
between disordered and ordered states that correspond to the functional catalytic states
(Keramisanou et al., 2006). This disordered region was also previously observed in our
lab by NMR (Chou et al., 2002). Furthermore, Arg 574 and Arg 509, both found in the
helicase motifs, are important in enhancing the catalytic activity of SecA (Keramisanou
et al., 2006).
During the translocation cycle, SecA goes from a low basal ATPase rate to eightfold higher translocation ATPase rate (Vrontou et al., 2004). Truncation of the C-terminal
one-third of SecA causes an unregulated, hyperactive ATPase rate (Karamanou et al.,
1999; Triplett et al., 2001). Deletion of the intramolecular regulator of ATP hydrolysis 1
(IRA1) also causes the unregulated ATPase activity of SecA. In the closed and compact
cytosolic form of SecA, IRA1 suppresses the ATPase rate of SecA but upon interaction
with the membrane or the translocon, IRA1 is released and the ATPase rate of SecA is
dramatically increased to help facilitate the translocation of the preprotein across the
inner membrane (Karamanou et al., 1999).
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1.7.1.3.SecB interactions
In order for preproteins to be translocated across the inner membrane posttranslationally by SecA in Gram-negative bacteria, the molecular chaperone SecB
recognizes and binds preproteins to keep them in an unfolded state. SecB can then target
them to the preprotein translocase SecA. SecB has a high affinity for the membranebound form of SecA (KD = 10-30 nM) (Vrontou and Economou, 2004). SecB is a
homotetramer and has three potential areas of interaction with SecA. One of the contact
regions is between the negatively charge surface formed by each dimer of SecB and the
zinc-binding domain at the extreme C-terminus of SecA. A second area involves the Cterminus of SecB and the interfacial region of the dimer (Patel et al., 2006) of SecA from
the B. subtilis structure (Hunt et al., 2002). The third area of interaction was discovered
by truncation of both SecA and SecB, which eliminated the other binding interactions.
This third interaction may not be stable enough to maintain association on its own. Even
though SecB is a tetramer and SecA is a dimer, the complex formed is asymmetric which
may have implication for preprotein translocation (Patel et al., 2006).

1.7.1.4.SecYEG binding
Several years ago it was shown that SecA interacts with the SecYEG channel, and
SecA was proposed to insert into the channel with the preprotein (Economou and
Wickner, 1994). Only recently have the molecular details of the SecA-SecY interaction
begun to be understood. Several indirect methods have been used to assess the SecASecYEG interactions (Snyders et al., 1997; van der Sluis et al., 2006; Karamanou et al.,
2008) but they have not provided conclusive evidence.
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Using an in-vivo site-directed cross-linking technique, Mori and Ito (Mori and Ito,
2006a) studied the SecA-SecY interaction by the incorporation of the photoactivatable
cross-linker in the cytoplasmic loops of SecY. Cross-linking was observed with SecA to
the C2, C4, C5, and C6 loops of SecY. The presence of NaN3, a known powerful
inhibitor of SecA translocation activity, enhanced cross-linking to C6 suggesting that this
interaction is likely to be dynamic during the translocation reaction. The interactions with
C2, C4, and C5 are more static in nature and the C5 loop appears to be involved in the
binding of the N-terminal two-thirds of SecA (Mori and Ito, 2006a). The C5 residue Arg
357 was subsequently shown to be essential for the initiation of the translocation cycle by
SecA (de Keyzer et al., 2007).
The interaction sites proposed by Mori and Ito (Mori and Ito, 2006a) were used to
design disulfide cross-linking experiments with SecA. Cys substitutions were made in the
C6 loop of SecY and the NBF I of SecA. The cross-links mapped one face of the NBF I
to the tip of the C6 loop of SecY. In another experiment, two linked SecY proteins were
used for cross-linking with SecA and a preprotein. The results indicated that one SecY
channel interacted with the preprotein while the second one bound the NBFI of SecA.
This suggests that SecYEG can function as a dimer with one active translocon for
preproteins and a second translocon for binding SecA (Osborne and Rapoport, 2007).
The structure of SecA bound to the SecYEG translocon has recently been solved
at 4.5 Å. This structure demonstrates that both SecA and the SecY complex undergo large
conformational changes upon binding. In this structure only one SecA molecule is bound
to one copy of the SecY channel. The majority of the interactions are made by the
preprotein cross-linking domain (PPXD) of SecA and the loops connection TMs 8-9 and
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TMs 6-7 of SecY. Additionally, the α-helical scaffold domain (HSD) makes extensive
interactions with SecY. Other minor interactions occur as well but these have small
contact surfaces and likely could not sustain the interaction alone. To correlate this
structure (Zimmer et al., 2008) with the previous disulfide cross-linking results (Osborne
and Rapoport, 2007), it was proposed that this new structure represents the active channel
through which preproteins are translocated. The inactive channel that interacts with the
NBF I was lost during detergent solubilization (Zimmer et al., 2008). Clearly, the SecASecY interaction is important in the translocation of preproteins and we are just
beginning to understand some of the molecular details of this dynamic interaction.

1.7.1.5.Interactions with phospholipids
In addition to its interactions with other components of the secretory pathway,
SecA can also interact and insert into the inner membrane. Protease protection assays in
the presence of inverted membrane vesicles, ATP, and preproteins, demonstrated that a
30 kD fragment of SecA is protected from the protease. N-terminal sequencing revealed
that this protected fragment started at residue 610 indicating that the 30 kD fragment is
composed of the C-terminal third of the protein (Price et al., 1996).
Other experiments have demonstrated that long-chain phospholipids analogues
cause SecA to monomerize. In addition to the change in oligomeric state, the
phospholipids also cause domain dissociation in SecA (Benach et al., 2003). Acidic
phospholipids are required for efficient translocation of preproteins by SecA.
Fluorescence experiments with SecA and labeled phospholipids revealed that SecA can
penetrate deep into the phospholipids bilayer. This also induces a partial unfolding or
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domain dissociation of SecA that could be important for the translocation cycle (Ulbrandt
et al., 1992).

1.7.1.6.Preprotein binding
The major function of SecA is the translocation of preproteins across the inner
membrane. The preprotein consists of two parts, the signal sequence and the mature
region and SecA interacts with both of these parts. Signal sequences can bind to SecA in
solution as well as in the presence of liposomes (Vrontou and Economou, 2004). Several
different regions in the N-terminal two-thirds of SecA have been proposed as the signal
sequence-binding site in soluble SecA (Kimura et al., 1991; Triplett et al., 2001; Hunt et
al., 2002; Baud et al., 2002; Chou and Gierasch, 2005; Papanikou et al., 2005; Gelis et
al., 2007) as well as SecA bound to liposomes (Musial-Siwek et al., 2005; Musial-Siwek
et al., 2007). Most of these observation or predictions have been made on the soluble
form of SecA, which may not be the physiologically relevant form of SecA to study
signal sequence interactions (Clerico et al., 2008). Another study indicated that the
nucleotide state of SecA can modulate the affinity of the signal sequence (Shin et al.,
2006). The recognition and binding of the mature portion of the preprotein is still poorly
understood. The binding site for the mature regions of the preprotein should have some
fundamental characteristics such as: binding to 20-30 amino acids at a time, no sequence
specificity, and a small bound versus unbound energy barrier (Vrontou and Economou,
2004). One study demonstrated that the mature portion of a preprotein could interact with
the PPXD of SecA (Papanikou et al., 2005). Despite several years of research effort and
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the central importance of this question, preprotein interactions with SecA are still not
clearly understood.

1.7.2. SecA crystal structures
The first crystal structure of dimeric SecA from Bacillus subtilis revealed the
structural architecture of the monomer, which consists of five different domains (Figure
1.8, A). The catalytic activity of ATP hydrolysis is carried out by the first nucleotide
binding fold (NBF I) in blue and the second nucleotide binding fold (NBF II) in purple.
These two domains have a ′RecA-like′ fold which creates the nucleotide binding site at
the interface between the domains. Additionally, NBF I and II share structural homology
with the superfamilies I and II ATP-dependent helicases. A unique domain in SecA is the
preprotein cross-linking domain (PPXD) in yellow, which interrupts NBF I (Hunt et al.,
2002) and has been demonstrated to bind preproteins (Vrontou and Economou, 2004;
Papanikou et al., 2005). The α-helical scaffold domain (HSD) in green follows the NBF
II and has been implicated as the conformational regulator of SecA (Mori and Ito,
2006b). The α-helical wing domain (HWD) in orange interrupts the HSD and can loosely
pack against the PPXD but the function of this domain has not been determined. The
carboxyl-terminal linker (CTL) in red at the C-terminus of the protein contains the zinc
binding motif and has also been shown to interact with phospholipids as well as SecB.
The last 40 residues at the extreme C-terminus were not resolved in the B. subtilis
structure (Hunt et al., 2002) or any of the subsequent crystal structures.
The only structure of the extreme C-terminus of SecA is a solution NMR structure
of the last 22 residues that includes the zinc binding motif (Dempsey et al., 2004). The
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Figure 1.8 Different structures of SecA
Three different crystal structures of SecA demonstrate that the overall domain
organization is similar but the preprotein cross-linking domain has three different
orientations. A. The B. subtilis structure (1M6N) has the PPXD in a closed form with
intramolecular interactions with the HWD. The last 40 residues are missing from this
structure Hunt et al., 2002). B. The NMR structure of E. coli SecA (2VDA) shows that
the PPXD has rotated away from the HWD and is in the open conformation. This
structure is missing the most of the CTL (Gelis et al., 2007). C. SecA structure from T.
maritima bound to the SecYEG translocon (3DIN). The translocon is not shown for
clarity. The PPXD has moved even further away from the HWD and has some
intramolecular interactions with NBF II. The CTL of SecA is missing from this structure
(Zimmer et al., 2008). D. Linear representation of SecA color-coded for the different
domains. The sequence numbering beneath the cartoon is for E. coli SecA.
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zinc is coordinated by three Cys and one His residues in the CXCXSGX8CH sequence.
The conserved Ser forms a strong hydrogen bond with the third Cys. This interaction
likely plays an important role in the stability of the structure. This zinc binding domain is
a key player in the interaction between SecA and SecB.
Other dimeric crystal structures of SecA from various prokaryotes species have
been reported (Sharma et al., 2003; Zimmer et al., 2006; Vassylyev et al., 2006;
Papanikolau et al., 2007) as well as a monomeric B. subtilis SecA structure (Osborne et
al., 2004) All of these structures have similar monomer architecture except for the
interface of the PPXD and HWD. In some structures the PPXD loosely packs against the
HWD in the so called ‘closed’ state (Figure 1.8, A) (Hunt et al., 2002; Sharma et al.,
2003; Zimmer et al., 2006; Vassylyev et al., 2006) while in other structures the PPXD
rotates about 60° and is no longer in contact with the HWD in a so called ‘open’ state
(Figure 1.8, B) (Papanikolau et al., 2007; Osborne et al., 2004). A recent elegant NMR
structure of full-length Escherichia coli SecA demonstrated that SecA visits both the
‘open’ and ‘closed’ conformations in solution but the major species is the ‘open’ state
(Gelis et al., 2007). The previously mentioned structure of SecA bound to the SecYEG
translocon shows that SecA undergoes another conformational change upon binding to
the translocon (Zimmer et al., 2008). The overall architecture remains the same but the
PPXD has rotated even further away from the HWD and interacts with both NBF II and
SecY. Another difference is the relative positions of the two NBFs. This structure was
solved with ADP-BeFx, which mimics transition state during ATP hydrolysis and shows
that NBF II has a rigid body rotation of about 15º towards the plane of the membrane.
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This positions Arg 574 (E. coli numbering) towards the γ-phosphate of the ATP to trigger
the hydrolysis reaction. Although these structures have started to provide atomic
resolution snapshots of SecA but none of these structures provide full mechanistic details
about SecA in its activated state prior to and during translocation.

1.7.3. Different conformations of SecA
In order for SecA to perform its required function as a preprotein translocase, it
must perform conformational gymnastics. In the cytosol, SecA exists in ‘closed’ dimeric
form and is protease resistant. Intramolecular interactions between the different domains
help stabilize this compact conformation. Binding of different ligands such as SecB,
phospholipids, and SecYEG trigger domain dissociation in SecA by weakening the
intramolecular interactions to different extents. This domain dissociation results in a more
open structure that is protease sensitive (Clerico et al., 2008). The conformational
changes of SecA will be further described in the introduction to Chapter 2.

1.7.4. Signal sequence interactions with SecA
In order to test the secondary structure hypothesis of signal sequences (Emr and
Silhavy, 1983) with SecA, our group performed line broadening and transfer Nuclear
Overhauser Effect (trNOE) NMR experiments using synthetic signal peptides and soluble
SecA (Chou and Gierasch, 2005). The observed trNOEs demonstrated that signal peptide
bound to SecA adopted an α-helical structure in the h- and c-regions. Differential line
broadening experiments indicated that one side of the helix form from residues in the hregion was more strongly bound to SecA. Additionally, the positive n-region of the signal
sequence also contributed to the binding interaction. Therefore, the electrostatic and
46

hydrophobic characteristics as well as the secondary structure are needed for signal
sequence-binding to SecA.
A considerable amount of effort has been expended in trying to determine the
signal sequence-binding site on SecA. Initial studies demonstrated that signal sequences
interact with the N-terminal two-thirds of SecA (Kimura et al., 1991; Triplett et al., 2001)
but further biochemical and biophysical experiments do not converge on one signal site
(Figure 3.3 and for further description and discussion see the introduction to Chapter 3).
Major conformational changes are induced in SecA after initial interaction with
preprotein and SecB. Very few signal sequence-binding studies have been performed on
this more open translocation-active form, which is likely to be more physiologically
relevant.

1.8. Statement of Dissertation
Protein secretion across or insertion into biological membranes occurs in all three
kingdoms of life. Approximately, one-third of a cell’s proteome is secretory and integral
membrane proteins (Papanikou et al., 2007). Over the last three decades considerable
work has been performed to understand the targeting of the secretory proteins to their
subcellular compartments and their active transport across membranes. Though
significant progress has been made, many of the mechanistic details are still unresolved.
In particular, the recognition mechanism of diverse signal sequences still remains elusive.
The studies of a truncated version of SecA, SecA64 (Triplett et al., 2001) and of
the ATPase enhancement of SecA in denaturant (Song and Kim, 1997) lay the
groundwork for this study. The SecA64 study demonstrated that the ATPase activated
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form of SecA bound signal peptides better than the full-length protein (Triplett et al.,
2001) while the denaturant study showed that low concentrations of denaturant have a
similar effect on the activation of the ATPase activity as SecA64 but in the context of the
full-length protein (Song and Kim, 1997). In this current study, full-length SecA in the
presence of low concentrations of urea was characterized for structural changes to
understand the conformational rearrangements of the activated translocation-competent
SecA. Furthermore, this work describes the interactions of signal peptides with the
cytosolic (solution) form of SecA as well as the translocation-active conformation of
SecA.
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CHAPTER 2
CHARACTERIZATION OF TRANSLOCATION-ACTIVE SECA

2.1

Introduction
SecA is a dynamic protein that visits different conformations during the

preprotein translocation cycle. In the cytosol, SecA is in a closed form and has low
ATPase activity (Schmidt et al., 2000). SecA can bind preproteins either in the cytosol or
at the membrane. In the case of Gram-negative bacteria, the preprotein/SecB complex
interacts with SecA already associated with the SecYEG translocon. These binding
interactions with other components of the secretory pathway induce a major
conformational change in SecA resulting in an open domain dissociated form (Clerico et
al., 2008). This form of SecA possesses a high ATPase activity (Lill et al., 1990), which
is used to help translocate the preprotein through the SecYEG channel.
Oliver and Beckwith (Oliver and Beckwith, 1982) first described SecA as a
peripheral inner membrane protein but a subsequent study demonstrated that SecA
partitioned between the cytosol and the inner membrane (Cabelli et al., 1991), and further
experiments indicated that SecA could insert into membrane vesicles (Ulbrandt et al.,
1992). Through protease-protection assays in membranes, Economou and Wickner
(Economou and Wickner, 1994) showed that a 30 kD fragment corresponding to the Cterminal one-third of SecA was protected upon interaction with membranes, and they
concluded it was inserted into the membrane. The cytosolic or solution form of SecA has
been studied by FRET analysis (Ding et al., 2003a) and cryo-electron microscopy, which
demonstrated that soluble SecA is in a closed dimeric conformation (Chen et al., 2008).
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Taken together these results clearly illustrate that SecA has at least two distinct
conformations, the closed cytosolic form and open membrane-bound form (Figure 2.1).
Studies performed on cytosolic SecA (c-SecA) have demonstrated that
temperatures slightly higher than physiological temperature induced an endothermic
conformational change (Schmidt et al., 2000; Fak et al., 2004). Using SecA mutants
discovered through genetic analysis (Fikes and Bassford, 1989) (Fortin et al., 1990)
(Oliver et al., 1990), Schmidt et al. (Schmidt et al., 2000) discovered at low temperatures
these mutants are in the same open conformation as is wild-type SecA at elevated
temperatures. These results suggest that the conformational changes observed at higher
temperatures or because of physiologically relevant mutations change the conformation
of SecA into a form similar to the membrane-bound form.
Driessen and coworkers (den Blaauwen et al., 1996) studied the effects of
different nucleotides on the conformation of cytosolic SecA (c-SecA). Trp fluorescence
revealed that ADP induced a closed form of SecA and the binding of an ATP analog,
AMP-PNP enabled SecA to adopt a more open conformation. This open conformation
was caused by the loosening of interactions between the C-terminal one-third of SecA
and the N-terminal region. These results suggest that a domain dissociation of the Cterminal region of c-SecA upon AMP-PNP binding could aid in the priming of SecA for
interaction with the membrane and/or SecYEG.
In another study using fluorescence resonance energy transfer (FRET) (Ding et
al., 2003b), the close proximity of the PPXD and the C-terminal one-third of SecA was
examined. This study demonstrated that ADP promotes a tight association between the
PPXD and HWD while higher temperature and binding to model membranes caused a
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Figure 2.1 Different conformations of SecA
SecA exists in at least two different conformations. In the cytosol SecA is in a closed
ADP-bound form with low ATPase activity. Various ligands such as lipids, SecB,
preprotein, and translocation as well as high temperature, denaturants, and truncation of
the C-terminus force SecA to adopt the open conformation. Adapted from Fak et al. (Fak
et al., 2004).
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dissociation of the two domains. Furthermore, the hyperactive azide-resistant mutant of
SecA (Oliver et al., 1990) is in an even more open conformation in the cytosolic form
(Ding et al., 2003b). The recent NMR structure of SecA (Gelis et al., 2007) argued that cSecA visits both the open and closed state but is predominantly in the open state (Figure
1.8, B). The NMR data on SecA was collected in the nucleotide-free form, which may
have influenced the promotion of the open state. The recent structure of truncated SecA
bound to the SecYEG translocon solved by Rapoport and colleagues (Zimmer et al.,
2008) was determined in the presence of ADP BeF3-, a transition-state analog. As
discussed in Chapter 1 section 1.7.2., this translocon-bound structure of SecA has the
PPXD in an even more open conformation (Figure 1.8, C). All of these results suggest
that the nucleotide bound to SecA influences PPXD and HWD dissociation and
reorientation.
To try to understand the conformational changes induced in SecA upon binding to
model membranes, Oliver and co-workers (Ding et al., 2001) employed fluorescence
experiments using SecA mutants containing single Trp substitutions to identify the
residues involved in phospholipid binding. SecA contains seven Trp residues (349, 519,
541, 622, 701, 723, and 775) (Figure 2.2) but Trp701, Trp723, and Trp775 located in the
C-terminal portion of SecA are the major contributors to the overall fluorescence. In
solution Trp723 and to a lesser extent Trp701 are solvent accessible while Trp775 is
buried. In model membranes, Trp723 is less solvent exposed, Trp775 becomes more
solvent exposed and Trp701 did not change in solvent accessibility. These results suggest
that the C-terminal portion of SecA is flexible and therefore, may be crucial for the
preprotein translocation cycle.
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Figure 2.2 Seven Trp residues in SecA
The NMR structure from E. coli (Gelis et al., 2007) (2VDA) illustrates the seven Trp
residues shown in the cyan spheres in SecA. The linear cartoon below the structure is
colored for the different domains in SecA and show the positions of each of the Trp
residues by the cyan boxes. *Indicate the Trp residues that contribute most to the overall
fluorescence in SecA (Ding et al., 2001).
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Natale et al. (Natale et al., 2005) utilized fluorescence spectral changes in single
Trp mutants of SecA along with acrylamide quenching to probe the structural
rearrangements of SecA upon binding to the SecYEG translocon. The binding of SecA to
the translocon induces SecA changes in the PPXD, NBF II and HWD. These results
demonstrate that SecA bound to SecYEG adopts a conformation that is different from the
cytosolic form and are observed in the recent truncated SecA/SecYEG structure (Zimmer
et al., 2008).
In another set of experiments using proteolysis and fluorescence of a fluoresceinlabeled SecY, SecA was observed to bind SecYEG in a protease-sensitive conformation
independent of nucleotide. The fluorescence experiments indicated that additional
conformational changes occur in the SecA/SecYEG complex upon ATP analog binding.
This change in conformation is transmitted from the NBFs of SecA to the pore region of
SecY. The studies suggest that there are several different conformational changes in the
SecA/SecYEG complex during the preprotein translocation cycle (Robson et al., 2007).
Despite many biochemical and biophysical studies, the conformational changes in
SecA during the translocation cycle are still unclear due to the lack of a good stable
model of the active state. Many of the previous studies have utilized only one technique
such as fluorescence and have used modified or mutated SecA protein. This chapter
describes the activation and conformational change of SecA in adopting the
translocation-active form. We use low concentrations of urea to activate SecA by domain
dissociation. Through various biophysical experiments, limited proteolysis, and domain
mapping, we have characterized a physiologically relevant, soluble form of SecA that
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reflects the functional conformation prior to preprotein translocation across the inner
membrane.

2.2

Results

2.2.1. Activation of SecA in low concentrations of urea
To generate an in vitro form of full-length SecA that represents the
conformational change during the early stages of translocation, we followed up on the
work of Song and Kim (Song and Kim, 1997), which demonstrated that the ATPase
activity of SecA becomes uncoupled in low concentration of denaturant. We performed
urea titrations to examine the ATPase activity of SecA at 22°C. As the concentration of
urea increased, the ATPase activity of SecA was enhanced to a peak rate at 2.2 M urea
(Figure 2.3). This is an eight-fold higher activity than SecA in 0 M urea. After this peak
in activity, the ATPase activity drops sharply and by 2.8 M urea no ATPase activity is
observed. This eight-fold activation of the ATPase activity of SecA in 2.2 M urea is
similar to the activation during preprotein translocation (Papanikou et al., 2004).

2.2.2. Structural analysis of intermediate
2.2.2.1.Tryptophan Fluorescence
The seven intrinsic Trp residues in SecA (Figure 2.2) provide us a tool to probe
the tertiary structure of SecA during the course of a urea melt. The emission maximum of
native SecA is 340 nm. Upon full denaturation in 8 M urea, the emission maximum red
shifts to 350 nm and decreases in intensity (Figure 2.4, A). During a urea melt at 22ºC,
SecA Trp fluorescence at 340 nm begins decreasing at 1.4 M urea and at 2.2 M urea
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Figure 2.3 Low concentration of urea stimulate the ATPase activity of SecA
The ATPase activity of SecA was measured as a function of urea concentration at 22ºC.
A peak in activity is observed at 2.2 M urea followed by a sharp decrease to no activity.
SecA in the absence of urea was set to 100% activity. The error bars represent the
standard deviation from three separate experiments.
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Figure 2.4 Changes in SecA tertiary structure
A. The Trp fluorescence change in SecA upon unfolding in urea at 22ºC. The red circles
show the Trp fluorescence of native SecA excited at 295 nm. Native SecA has an
emission peak around 340 nm. The blue circles show unfolding SecA in 8 M urea. Upon
unfolding the fluorescence signal decreases and red-shifts to about 350nm. B. The Trp
fluorescence was normalized to SecA in the absence of urea. The urea melt of SecA at
22ºC shows an intermediate from 2.5 to 3.4 M urea and SecA is fully unfolded by 4 M
urea.

60

61

about 50% of Trp fluorescence is lost. The maximal ATPase activity of SecA is in 2.2 M
urea. The fluorescence data suggests the presence of an intermediate in 2.2 M urea region
of the melt. The fluorescence remains nearly constant from 2.5 M urea to 3.4 M urea and
SecA completely unfolds around 4 M urea. Trp 701, 723, and 775 have been shown to
contribute most to the overall Trp fluorescence of SecA (Ding et al., 2001). Both Trp 701
and 723 are located in the HWD while Trp 775 is located in the C-terminal HSD. Trp775
is the most solvent inaccessible of the three Trp residues so the intramolecular
interactions holding the C-terminal HSD to the other domains has been disrupted has
been disrupted in 2.2 M urea. Taken together these results suggest that the increased
ATPase activity of SecA is occurring due to a conformational change/unfolding event in
the C-terminus of SecA.

2.2.2.2.Far-UV CD
In order to gain further understanding of the structural changes that occur in
SecA, we examined the far-UV CD spectra in several urea concentrations (Figure 2.5).
Due to the presence of urea, spectra could only be recorded to 215 nm. The helical
content of SecA decreases as the urea concentration is increased. SecA in 2.2 M urea has
lost about 25% of its helical content (Figure 2.6, green diamonds). Additionally, a
structured intermediate is likely since there is very little change in the helical content
from 2.2 M urea to 3.0 M urea. This loss of helical structure is likely attributed to
unfolding or domain rearrangement in the C-terminal portion of the protein, in particular
part of the HSD and the HWD.
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Figure 2.5 Secondary structural changes in SecA in urea
The far-UV CD of SecA in different concentrations of urea at 22ºC shows a decrease in
the helical content of SecA as the concentration of urea is increased. SecA in the cluster
of the spectra from 2.2 M to 3.0 M urea indicate the presence of an intermediate.
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Figure 2.6 Activity and structural changes of SecA in urea
Low concentrations of urea activate the ATPase activity SecA. The red circles represent
the percent of ATPase activity of SecA from Figure 2.3. The blue squares show the Trp
fluorescence of SecA at 340 nm as shown in Figure 2.4. The green diamonds show the
far-UV CD signal of SecA at 222 nm. The Trp and CD signal were normalized to SecA
in the absence of urea. SecA in 2.2 M urea has an eight-fold enhancement in activity over
SecA in 0 M urea and both the Trp fluorescence and far-UV CD indicate the presence of
an intermediate at this urea concentration.
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When the ATPase activity, Trp fluorescence, and far-UV CD are plotted together
(Figure 2.6), it is clear that the peak ATPase activity coincides with a structured
intermediate at 2.2 M urea. We term this intermediate form of SecA u-SecA.

2.2.2.3. Limited proteolysis
To gain further insight into how u-SecA differs structurally from the c-SecA
structure, we performed a time course of limited proteolysis on both forms of SecA using
α-chymotrypsin (Figure 2.7). Strikingly, u-SecA is much more protease sensitive than cSecA indicating that u-SecA is in a domain dissociated conformation similar to what has
been observed for SecA in the presences of phospholipids (Ulbrandt et al., 1992).
Quantitation of the amount of full-length SecA at each point in the digestion shows that
in c-SecA 40% of full-length SecA remains after 15 minutes of digestion while fulllength SecA in u-SecA is completely digested by five minutes (Figure 2.7, B). To further
understand into the conformational change in u-SecA, we performed the chymotryptic
digestion followed by detection with the region-specific antibodies developed by
Ramamurthy and Oliver (Ramamurthy and Oliver, 1997) (Figure 2.8). These antibodies
were generated before the first crystal structure of SecA was solved but the antibodies
still roughly match the six different domains in SecA.
The region-specific antibody detection shows that a portion of NBF I, the Cterminal region including the HWD, the C-terminal HSD, and the CTL are the regions of
the protein cleaved in both forms (Figure 2.9). These results are consistent with the
fluorescence and near-UV CD suggesting that the C-terminal portion of the protein is
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Figure 2.7 Limited proteolysis demonstrates u-SecA is in an open conformation
A. A time course of limited proteolysis of c-SecA and u-SecA was analyzed by an 8%
SDS-PAGE and stained with Coomassie blue. The lanes are as follows: (1) SecA no
digestion, (2) c-SecA 10 sec, (3) u-SecA 10 sec, (4) c-SecA 1 min, (5) u-SecA 1 min, (6)
c-SecA 2 min, (7) u-SecA 2 min, (8) c-SecA 5 min, (9) u-SecA 5 min, (10) c-SecA 10
min, (11) u-SecA 10 min, (12) c-SecA 15 min, (13) u-SecA 15 min. B. Quantification of
the amount of full-length SecA remaining at each time point and is the average of two
separate experiments. The intensity of the bands were normalized to undigested SecA
from lane 1.
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Figure 2.8 SecA region-specific antibodies
The region-specific antibodies were generated as described by Ramamurthy and Oliver
(Ramamurthy and Oliver, 1997). The cartoon representation of E. coli SecA is shown on
the top and is color-coded for the different domains. The residues recognized by the six
different antibodies (A1-A6) are indicated above the cartoon and the corresponding
regions in the NMR structure from E. coli (Gelis et al., 2007) (2VDA) are show below.
Most of the CTL domain was not determined in the NMR structure so this region is
indicated by the red line in the A6 structure.
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Figure 2.9 Different domain proteolysis in c-SecA and u-SecA
A. The region-specific antibodies against SecA were used to examine the digestion
pattern of c-SecA. The 15-minute time point is shown with the molecular weight ladder
indicated on the right side of the gel. The labels are as follows: C–Coomassie blue stained
gel, A1–antibody against residues 1-209, A2–antibody against residues 211-350, A3–
antibody against residues 351-509, A4–antibody against residues 519-664, A5–antibody
against residues 665-820, A6–antibody against residues 822-901. Red boxes indicate
proteolytic fragments that are similar in both c-SecA and u-SecA while the blue boxes
demonstrate different proteolytic fragments. B. The region-specific antibodies against
SecA were used to examine the digestion pattern of u-SecA. The 5-minute time point is
shown with the molecular weight ladder indicated on the right side of the gel. The labels
are the same as in A.
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undergoing a conformational change in 2.2 M urea, and that this region of the protein
could be experiencing similar changes during preprotein recognition at the membrane.

2.2.2.4.Mass Spectrometry of proteolytic fragments
The predicted chymotrypsin cleavage sites from ExPASy (Gasteiger et al., 2005)
based on the linear SecA sequence do not completely explain all of the proteolytic
fragments. To further identify these chymotryptic fragments in u-SecA, we utilized
matrix assisted laser desorption ionization mass spectrometry (MALDI-MS). Four of the
u-SecA fragments were analyzed but due to the large size of SecA (901 amino acids) and
the large number of chymotrypsin cleavage sites, none the u-SecA fragments contained a
homogenous SecA fragment. Based on the MS peak intensities (see Materials and
Methods), predicted chymotrypsin cleavage sites, and antibody mapping, we determined
the most abundant proteolytic species in the u-SecA fragments (Figure 2.10).
The U50 fragment (Figure 2.10, C) contained peptides covering almost the entire
SecA sequence. To determine the abundant 50 kD proteolytic fragment(s) in this sample,
we analyzed the high-intensity peaks (Figure 2.10, C, gray boxes) and discovered two
SecA chymotryptic fragments were the abundant species. The first fragment contains
NBF I, PPXD, and half of NBF II, while the second fragment consists of the C-terminal
portion of the PPXD, NBF II, N-terminal HSD, and the HWD. These two fragments
differ only by 1 kD hence they cannot be resolved by SDS-PAGE. The U30 sample was
analyzed using the same method (Figure 2.10, D). This most abundant fragment is 32 kD
and is located at the C-terminal end of SecA. Two other minor species of 33 kD and 32
kD are present in the U30 sample and are in the N-terminal two-thirds of SecA. The
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Figure 2.10 Mass spectrometry determined protease cleavage sites
A. A four-minute digestion of u-SecA followed by Coomassie blue staining (C) and
region-specific antibody detection. The boxes indicate the chymotryptic u-SecA fragment
that was analyzed by MALDI-MS/MS. The molecular weight standard is indicated on the
left of the gel. B. The notation used to present the MS data in C and D. Manual analysis
used high-intensity peaks to determine the abundant species in each u-SecA fragment
analyzed by MALDI-MS/MS (see Materials and Methods). C. MALDI-MS analysis of
the U50 fragment shows peptide coverage across almost the entire sequence. Highintensity peak data determined that U50 contained two predominant fragments of 51 kD
and 52 kD. D. MALDI-MS analysis of the U30 fragment shows peptide coverage across
almost the entire sequence. High-intensity peak data determined that U30 contained one
major C-terminal fragment of 32 kD and two other minor N-terminal fragments of 33 kD.
E. Combining the MS and antibody data, a map of the chymotrypsin cleavage sites in uSecA, shown below the cartoon, was determined. The large, medium, and small arrows
indicate the relative cleavage at each of the sites. The chymotrypsin cleavage sites in cSecA, shown above the cartoon, were determined based on the probability of cleavage at
a specific residue and surface accessibility (see text for details).
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smaller U27 and U20 fragments were also analyzed but due to numerous MS identified
peptides, an abundant fragment(s) could not be determined. Using the peptide identified
by MS experiments and the antibody data, we were able to determine the relative
cleavage of the chymotrypsin sites in u-SecA (Figure 2.10, E). The surface accessibility
calculation of the side chain residues of the E. coli NMR structure (2VDA) using
VADAR software (Willard et al., 2003) identified the surface exposed aromatic residues.
This data along with the predicted cleavage sites from ExPASy (Gasteiger et al., 2005)
enabled us to determine the chymotryptic site in c-SecA. Taken together this data
demonstrates that the C-terminal portion of both c-SecA and u-SecA are proteolytically
labile. A stable 30 kD fragment is generated if cleavage occurs at Trp622 prior to
digestion of other parts of HWD, HSD, and CTL. This C-terminal fragment is consistent
with the 30 kD membrane-inserted domain characterized by Wickner et al. (Price et al.,
1996).

2.2.2.5.Oligomeric state of u-SecA
One of the many unresolved questions about SecA’s molecular mechanism during
the translocation cycle is whether it functions at the membrane as a dimer or a monomer
(see Chapter 1 section 1.7.1.1. for further discussion). In the case of u-SecA, we also
needed to determine the oligomeric state of the protein. Typical experiments such as sizeexclusion chromatography yielded ambiguous results so we performed velocity analytical
ultracentrifugation (AUC) experiments. C-SecA was used as a control since it has
previously been shown by this method to be a dimer (Woodbury et al., 2002). At 2 µM, 5
µM, and 10 µM concentrations, c-SecA exists in a dimeric form (Figure 2.11, A) but
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Figure 2.11 AUC of c-SecA and u-SecA
A. C-SecA at 5 µM was analyzed by velocity analytical ultracentrifugation. The top of
the graph shows absorbance scans of the cell with the black symbols indicating the scans
at the beginning of the centrifugation run and red symbols representing the scans at the
end of the run. The scans were fit to a continuous c(s) distribution model using SEDFIT
software (Schuck et al., 2002). The sedimentation coefficient translated into a molecular
weight of 203 kD, which is 1 kD off from the calculated 204 kD molecular weight of
dimeric SecA. B. The same analysis as in A using 5 µM u-SecA. U-SecA sediments
much faster than c-SecA and application of the continuous distribution model indicates
large molecular weight species. This indicates that u-SecA may be aggregating.

78

79

u-SecA was found to be in several higher molecular weight species (Figure 2.11, B).
These larger species are likely due to protein aggregation. To determine if u-SecA was
aggregating, we used a gluteraldehyde cross-linking approach. Gluteraldehyde is a nonspecific amine-amine cross-linker so residues in close proximity to each other will be
cross-linked. We used this method to determine the oligomeric state of both c-SecA and
u-SecA at several different protein concentrations (Figure 2.12). C-SecA is mostly in a
dimeric state as expected but u-SecA is found in a monomeric form. As the protein
concentration of u-SecA is increased, some u-SecA is in the dimeric form as well as in an
aggregated form. This experiment explains the higher molecular species found in the
AUC experiments with u-SecA. This result demonstrates that u-SecA is mostly in a
monomeric form at low protein concentration and that SecA unfolds as a monomer not
through a dimeric intermediate as previously reported (Doyle et al., 2000)

2.3.

Discussion
SecA in the cytosol is in a compact state with low basal level of ATPase activity

and the atomic details have been described by the available structures (Hunt et al., 2002;
Sharma et al., 2003; Osborne et al., 2004; Zimmer et al., 2006; Vassylyev et al., 2006;
Papanikolau et al., 2007). On the other hand, little is actually understood about the highly
active membrane/translocon bound form of SecA. Therefore, we generated and
characterized u-SecA: a full-length, soluble urea intermediate that is in an open and
active physiologically relevant conformation mimicking the translocation-active form.
Various studies have demonstrated that when SecA interacts with either the
phospholipids membrane or the SecYEG translocon, massive structural rearrangements
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Figure 2.12 Cross-linking demonstrates u-SecA is a monomer
C-SecA and u-SecA oligomeric state was determined by gluteraldehyde cross-linking and
run on a 6% tricine SDS-PAGE gel. The molecular weight standard is indicated on the
left side and the different oligomeric forms of SecA are indicated on the right side. The
lanes are as follows: (1) 0.5 µM cross-linked c-SecA, (2) 1.0 µM cross-linked c-SecA, (3)
2.5 µM cross-linked c-SecA, (4) 5.0 µM cross-linked c-SecA, (5) 1.0 µM non crosslinked SecA, (6) 0.5 µM cross-linked u-SecA, (7) 1.0 µM cross-linked u-SecA, (8) 2.5
µM cross-linked u-SecA (9) 5.0 µM cross-linked u-SecA. C-SecA is predominately in a
dimeric form while u-SecA is in a monomeric form. The diffuse nature of cross-linked
band is due to intramolecular cross-linking.
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occur (Economou and Wickner, 1994; Ding et al., 2001; Natale et al., 2005; Robson et
al., 2007). This conformational change causes the cytosolic protease-resistant SecA to
adopt an open, domain-dissociated, and protease-sensitive form. Through limited
chymotrypsin proteolysis, we determined that NBF I is destabilized in u-SecA (Figure
2.9, B, A1 lane). The unfolded nature of this domain in u-SecA suggests that it is missing
an interaction partner. Supporting our observation is a study by Osborne and Rapoport
(Osborne and Rapoport, 2007), which demonstrated that NBF I of SecA is involved in the
binding interaction with SecY.
In our limited protease digestion studies, the PPXD in u-SecA can be subdivided
into two regions where one region is more protease sensitive than the other (Figure 2.9,
B, A2 lane). This stabilization of one portion of the PPXD is consistent with the crystal
structure of SecA /SecYEG complex (Zimmer et al., 2008), which shows that the PPXD
has rotated far away from the HWD and makes molecular interactions with NBF II. This
crystal structure also supports our observation that portions of the PPXD, NBF II, and the
long helix from the HSD form a stable core in the translocation-active form of SecA.
Previous data has suggested that in the presence of anionic membranes SecA
partially unfolds and this unfolding event increases membrane insertion (Ulbrandt et al.,
1992). Other evidence showed that about one third of SecA can insert into the membrane
(Price et al., 1996). Since Trp 701, 723, and 775 contribute most to the overall Trp
fluorescence (Ding et al., 2001), the C-terminal third of SecA can interact with the inner
membrane. Our biophysical, proteolysis, and MS data demonstrates that the HWD, Cterminal HSD, and CTL of u-SecA have dissociated from the rest of the molecule. The
proteolysis and MS results indicate a stable 30 kD fragment from the C-terminal one-
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third of SecA is generated (Figure 2.9, B, A5 and A6 lanes and Figure 2.10, D). This Cterminal region is highly protease sensitive in u-SecA but if chymotrypsin cleavage first
occurs at Trp 623, the released C-terminal region can refold into a more stable fragment.
This 30 kD fragment is similar to protected membrane-inserted fragment identified by
Price et al. (Price et al., 1996). The domain dissociation in activated SecA causes the
release of IRA 1 located in the C-terminal HSD increasing the ATPase activity required
for preprotein translocation (Karamanou et al., 1999). This conformational change in
SecA primes the molecule for preprotein translocation and also could reveal a preprotein
interaction sites that are not accessible in the cytosolic form of SecA.
In our studies, we determined that u-SecA is in a mostly monomeric form, which
is consistent with the crystal structure of SecA bound to SecYEG (Zimmer et al., 2008)
and other translocation experiments (Duong, 2003; Osborne et al., 2004; Osborne and
Rapoport, 2007). This dissociation of the dimer for translocation likely reveals residues
needed for specific SecY binding interactions. Additionally, we demonstrated that uSecA begins to nonspecifically aggregate at higher protein concentrations. The dimer
dissociation into the activated translocation state reveals hydrophobic surfaces for
binding interactions with SecY, preprotein, and the inner membrane. In u-SecA these
interaction region are unsatisfied leading to aggregation. These observations suggest that
the monomeric form of SecA is important in the translocation cycle.
Using our results in conjunction with previous studies, we propose a model of
SecA interactions with the inner membrane and the SecYEG translocon. Upon interaction
with the translocon, the SecA dimer dissociates into a monomer and undergoes massive
structural rearrangements. This conformational change breaks PPXD interactions with the
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HWD and promotes NBF I binding to the translocon (Figure 2.13). The loss of the PPXD
interactions drive the HWD, C-terminal HSD, and CTL insertion into the membrane,
which in Gram-negative bacteria induces SecB dissociation. These new interactions
create the proper positioning of SecA for the productive translocation of preproteins.
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Figure 2.13 Model of the conformation change in SecA upon binding SecYEG
The different domains of SecA have been color-coded: blue, NBF I; yellow, PPXD;
purple, NBF II; green, N-terminal HSD; orange, HWD; dark green, C-terminal HSD; and
red, CTL. (1) Cytosolic SecA is in a closed antiparallel dimeric form and has low ATPase
activity. (2) Upon interaction with SecY the SecA dimer dissociates. (3) The HWD, Cterminal HSD, and CTL dissociate from the rest of the SecA monomer and insert into the
membrane. This new conformation positions SecA on the SecYEG translocon for
productive translocation of preproteins.
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2.4.

Materials and Methods

2.4.1. Recombinant DNA experiments
2.4.1.1.Cloning of SecA gene
The SecA gene was amplified by PCR from the pT7-SecA2 plasmid (D. Oliver,
Wesleyan University) using forward primer (5′-GGAATTCCATATGCCTAATCAA
ATTGTTAAC-3′; introduced restriction enzyme sites are underlined) and reverse primer
(5′-CCGCTCGAGTTATTGCAGGCGGCCATGGC-3′) using Taq DNA Polymerase
(New England Biolabs, Ipswich, MA). The 2.7-kb PCR fragment was subcloned into the
pGEM®-T vector (Promega, Madison, WI). The resulting plasmid was digested with
NdeI/XhoI restriction enzymes (New England Biolabs, Ipswich, MA) and ligated into the
same sites in pET17b (Novagen, Madison, WI) creating the pET-17b-FL SecA plasmid.
DNA sequencing (Davis Sequencing, Davis, CA) verified the correct sequence of the
SecA gene.

2.4.1.2.Site-directed mutagenesis
Sequencing results from the pET-17b-FL SecA revealed the presence of two point
mutations. One mutation was silent while the other one changed an amino acid T371A.
The mutagenesis primer (5’-CCAGAACGAAAACCAAACGCTGGCTTCGATCACC3’) and its complement (the single nucleotide change underlined) were used to change the
Ala back to Thr at position 371. Pfu Turbo DNA polymerase (Stratagene, La Jolla, CA)
was used with 50 ng of pET-17b-FL SecA 371A and 125 ng of each primer to
88

incorporate the single nucleotide change following the manufacture’s protocol. DNA
sequencing (Davis Sequencing, Davis, CA) verified the incorporation of the mutation in
the SecA gene.

2.4.2. Protein expression and purification
The pET-17b-FL SecA plasmid was transformed into the BL21 (DE3) bacterial
strain. Cells were grown at 37°C to OD600 of 0.5 in LB supplemented with LinA salts and
50 µg/ml ampicillin. Expression of SecA protein was induced by the addition of IPTG to
a final concentration of 0.75 mM and the culture was grown for another 2.5 hours at
37°C. The bacterial cells were pelleted, resuspended in lysis buffer (50 mM Tris pH 7.6,
100 mM NaCl, 1 mM DTT), frozen in liquid nitrogen, and stored at -80°C until
purification.
SecA protein was purified as described previously (Fak et al., 2004) with some
modifications. Bacterial cells were treated with a cocktail of protease inhibitors (150 µM
PMSF, 250 µg leupeptin, 10 µg pepstatin, 150 µM ABESF) followed by lysis. Cell lysis
was performed either by lysozyme treatment and sonication or by microfluidics system.
For lyssozyme treatment, cells were thawed and 20 mg of lysozyme was added (per liter
of original culture). The cells were incubated on ice for 20 minutes and then 4 mg of
DNase I was added (per liter of original culture) and incubated on ice for 10 minutes. The
cells were sonicated for 30 seconds followed by two minutes on ice for a total of five
cycles. For lysis by the microfluidics system, the cells were thawed and the total volume
was increase to 30 ml with lysis buffer. The cells were passed through the micro
fluidizer® processor (Microfluidics, Newton, MA) at a pressure of 16,000 PSI two times.
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After a 10,000 rpm spin at 4°C, the supernatant was passed through a 0.22 µm filter and
loaded onto a DEAE Sepharose CL-6B (Sigma, St. Louis, MO) column equilibrated with
50 mM Tris pH 7.6, 1 mM DTT, 0.025% NaN3. The protein was purified on an AKTA
purification system (GE Healthcare, Piscataway, NJ) using a 100 ml salt gradient from 0
to 1 M NaCl. Fractions were run on 8% Tricine SDS-PAGE. Relevant fractions
containing the SecA protein were pooled and loaded onto a SP Sepharose Fast Flow
(Sigma, St. Louis, MO) column equilibrated with 50 mM HEPES pH 7.5, 1 mM DTT,
0.025% NaN3. The loaded protein was purified using a 100 ml salt gradient from 0 to 1
M NaCl. Fractions were run on 8% SDS-PAGE to determine which fractions contained
SecA protein and the relevant fractions were concentrated to a final volume of 2.5 - 5 ml.
The concentrated SecA protein was injected onto a Superdex 200 prep grade (GE
Healthcare, Piscataway, NJ) gel filtration column equilibrated with 25 mM Tris pH 7.6,
150 mM KCl, 1 mM MgCl2. The relevant fractions containing pure SecA were pooled,
concentrated, snap-frozen in liquid nitrogen, and stored at -80°C. Protein concentration
was determined by absorbance at 275 nm (the peak absorbance for SecA in an
absorbance scan) after dilution into 6 M guanidinium-HCl, 20 mM sodium phosphate pH
6.5, assuming an extinction coefficient of 0.73 OD per mg mL-1. Each batch of protein
was checked for ATPase activity by the enzyme-coupled ATPase assay and secondary
structure by far-UV CD.

2.4.3. Enzyme-coupled ATPase assay
The ATPase activity of purified SecA was measured by the steady-state enzymecoupled ATPase assay. This assay uses pyruvate kinase and lactate dehydrogenase to
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couple the ATP hydrolysis to the conversion of NADH to NAD+ (Norby, 1988). To preequilibrate the sample, 400 nM SecA was added to 50 mM Tris pH 8.0, 30 mM KCl, 30
mM NH4Cl, 1 mM DTT, 5 mM Mg(OAc)2, 3 mM phospho(enol)pyruvate, 10 U of
pyruvate kinase, and 14.4 U of lactate dehydrogenase at 37°C for 15 minutes. After preequilibration, 0.5 mM ATP and 0.25 mM NADH was added to the reaction mixture and
the change in transmittance at 340 nm was monitored using the J715 spectropolarimeter
(JASCO) instrument at 37°C for 16 minutes. The rate of hydrolysis was determined by
changing the percent transmittance to absorbance. The absorbance at 340 nm over time
was plotted excluding the first 60 seconds in which the reaction was achieving steadystate and the slope was determined by linear least squares curve fitting. The change in
absorbance is directly proportional to the mole of NADH hydrolyzed using the ε340 of
NADH as 6.22 x103 cm-1 M-1. The correspondence between NADH hydrolyzed and ATP
hydrolysis is 1:1, therefore, the rate of ATP hydrolysis is equal to the rate measured for
NADH depletion. The ATPase activity was expressed as pmol ATP hydrolyzed/µg SecA
minute and was the average of three independent measurements.

2.4.4. Far-UV CD
CD spectra of proteins were measure using a J715 spectropolarimeter (JASCO).
Spectra were taken in the far-UV region from 195-250 nm using a 1-mm pathlength cell.
Scan speed was 20 nm/min and five scans were averaged. The samples were in 300 µl of
10 mM KHPO4 pH 7.6 and 1 mM MgCl2 at a concentration of 0.5 or 1 µM. The spectra
were buffer corrected.
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2.4.5. ATPase assay in urea
The ATPase activity of SecA in various urea concentrations was measured using
the malachite green-ammonium molybdate ATPase assay (Lanzetta et al., 1979) with ophosphoric acid (Sigma, St. Louis, MO) as a standard curve. After equilibration at 22°C
for 12 – 14 hours of 1 µM SecA in 50 mM Tris pH 8.0, 30 mM KCl, 30 mM NH4Cl, 5
mM Mg(OAc)2, 1 mM DTT with various concentrations of urea, 5 mM ATP was added
and the reaction was incubated for one hour at 22°C. The absorbance was measured at
660 nm using a Genesys 10 UV scanning spectrophotometer (Thermo Electron Corp).

2.4.6. Equilibrium fluorescence measurements
Samples containing 1 µM SecA were incubated at 22°C with various
concentrations of urea in 50 mM Tris pH 8.0, 30 mM KCl, 30 mM NH4Cl, 5 mM
Mg(OAc)2, 1 mM DTT for 12-14 hours. Trp fluorescence of SecA was measured using a
Photon Technology International QM-1 spectrofluorometer at 22°C. The fluorescence
excitation wavelength was 295 nm and the emission spectra were measured from 300 to
380 nm. The excitation and emission bandwidths were both set to 2 nm. The fluorescence
signal at 340 nm was plotted against the urea concentration and corrected for background
fluorescence using urea buffer.

2.4.7. CD measurements in urea
Far-UV CD measurements of 1 µM SecA in 20 mM HEPES pH 7.5, 50 mM KCl,
1 mM MgCl2, 1 mM DTT with various concentrations of urea incubated at 22°C
overnight were recorded on a J715 spectropolarimeter (JASCO) from 215-250 nm using
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a 1-mm pathlength cell. Scan speed was 20 nm/min and five scans of each sample were
averaged. Spectra were taken of urea buffer to substrate any background signal.

2.4.8. Limited proteolysis
C-SecA in 20 mM HEPES pH 7.5, 50 mM KCl, 1 mM MgCl2, 1 mM DTT and uSecA at 2.5 µM in 20 mM HEPES pH 7.5, 50 mM KCl, 1 mM MgCl2, 1 mM DTT, 2.2 M
urea were generated by incubation at 22ºC for four hours. The samples were subjected to
a time course of limited α-chymotrpysin (1:150 w/w) digestion from 0 to 60 minutes. At
each time point, adding 3X SDS-PAGE sample buffer and flash freezing in liquid
nitrogen quenched the digestion. Samples were either boiled and subjected to SDS-PAGE
or stored at -80°C until further use. The samples were run in duplicate on two 8% or 10%
SDS-PAGE gels. The gels were either stained with Coomassie blue or transferred to
PVDF membrane for further analysis.

2.4.9. Antibody Detection
Digested c-SecA and u-SecA protein transferred to PVDF membrane was
detected with region-specific SecA antiserum (Ramamurthy and Oliver, 1997) to
determine the identity of the proteolytic bands. The blots were blocked overnight at 4°C
or at room temperature for one hour in 5% non-fat milk in Tris-Buffered Saline with
0.5% Tween 20 (TBS-T). After washing with TBS-T, the blot was probed with one of the
region-specific antibodies at 1:5000 dilution in TBS-T for one hour at room temperature.
Next, a secondary goat anti-rabbit IgG alkaline phosphatase (AP) conjugated antibody
(Sigma) was used according to the manufacturer’s protocol. Antibodies were detected by
AP Lumino (Pierce, Rockford, IL) using a G:Box gel documentation unit (Syngene,
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Frederick, MD). Blots were stripped in 50 mM Tris pH 6.8, 2% SDS, and 100 mM βmercaptoethanol buffer at 55°C for one hour. The blots were then reprobed with the
secondary antibody, and if no background signal was detected, the blot was blocked and
probed with the other region-specific antibodies following the above protocol.

2.4.10. Mass spectrometry
Four u-SecA fragments, U50, U30, U27, and U20 numbered for their apparent
molecular weight, were analyzed by MALDI-MS/MS. The fragments were excised from
8% tricine SDS-PAGE gel using a clean razor and analyzed by the Center for Advanced
Proteomics Research at the New Jersey Medical School of the University of Medicine
and Dentistry of New Jersey. The gel pieces were washed with 30% acetonitrile in 50
mM ammonium bicarbonate followed by reduction with DTT and alkylation with
iodacetamide. The samples were further digested with trypsin at 37°C overnight. The
resulting trypsin digested peptides were extracted with 1% trifluoracetic acid two time
followed by 80% acetonitrile. The samples were concentrated using a speed vac and
desalted using C18 ZipTips. The SecA peptides were mixed in a 1:1 ration with 7 mg/ml
α-cyano-4-hydroxy-cinnamic acid and spotted onto the MALDI plate. The data was
analyzed using the local Mascot search against the E. coli SecA sequence. The variable
modifications employed were oxidized methionine and carbamidomethyl labeledcystenine and the error of the MS was within 50 ppm.
Due to the heterogeneous nature of the original α-chymotrypsin fragments further
manual analysis was performed. Taking into consideration all of the peptides that were
detected by the MS analysis, the size of the original chymotrypsin U50 fragment would

94

correspond to an 83 kD fragment. In the mass spectrum, a single peak of high intensity
does not correlate to the most abundant peptide but if most of the intense peaks cluster to
one region of the protein, that region is likely the most abundant species in the original uSecA chymotryptic fragment. A threshold of 10% intensity was set to determine all of the
high intensity peaks. All of the high-intensity peaks corresponding to the four original
fragments were mapped onto the SecA sequence. Based on the predicted chymotrypsin
cleavage sites along with the intensity analysis, the abundant species in the original U50
and U30 SecA fragments were identified. For the smaller U27 and U20 fragments, the
clustering of the MS intensities no longer applies due to the large number of proteolytic
fragments of similar sizes. The sequencing data from the MS/MS was used to determine
if a particular chymotrypsin cleavage site was used. If any of the aromatic residues
appeared in the sequenced peptide of all four u-SecA fragments more than two times, this
residue was not considered to be cleaved in the original chymotryptic digestion. From
this analysis the cleavage sites in u-SecA were assigned.

2.4.11. Velocity analytical ultracentrifugation
C-SecA in 20 mM HEPES pH 7.5, 50 mM KCl, 1 mM MgCl2, 1 mM TCEP and
u-SecA in 20 mM HEPES pH 7.5, 50 mM KCl, 1 mM MgCl2, 1 mM TCEP, 2.2 M urea,
at 2 µM, 5 µM, and 10 µM were equilibrated overnight at 22°C. SecA samples and buffer
were loaded into cells containing two-sector centerpieces. The An-60 Ti rotor was
equilibrated to 22ºC prior to the AUC run. The three separate cells containing samples
were centrifuged at 30,000 rpm until sedimentation of the protein was complete. Radial
scans measured the absorbance profile of each of the three samples at four-minute
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intervals. The sedimentation coefficient was determined using the SEDFIT software
(Schuck et al., 2002) using the continuous c(s) distribution model. The partial –specific
volume, density, and viscosity of both samples were calculated using the freeware
program SEDNTERP (http://www.jphilo.mailway.com/). The partial-specific volume
used for both samples is 0.7335. The density and viscosity values used are 1.00071 and
0.01002 for c-SecA and 1.03508 and 0.010997 for u-SecA.

2.4.12. Gluteraldehyde Cross-linking
C-SecA in 20 mM HEPES pH 7.5, 50 mM KCl, 1 mM MgCl2, 1 mM DTT and uSecA in 20 mM HEPES pH 7.5, 50 mM KCl, 1 mM MgCl2, 1 mM DTT, 2.2 M urea were
equilibrated for four hours at 22°C. Gluteraldehyde was added to a final concentration of
0.1% and incubated at room temperature for two minutes. The cross-linking was
quenched by the addition of 100 mM Tris pH 8.0. The samples were boiled for five
minutes and loaded onto a 6% Tricine SDS-PAGE. The proteins were visualized by
staining the gel with Coomassie Blue.
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CHAPTER 3
SIGNAL SEQUENCE INTERACTIONS WITH CYTOSOLIC SECA AND
TRANSLOCATION-ACTIVE SECA

3.1.

Introduction
A critical step in the post-translational secretion pathway in bacteria is the

recognition and binding of the signal sequence by SecA. After the preprotein has been
translated by the ribosome, either SecB interacts with the mature region of the preprotein
to maintain it in an unfolded state or the preprotein is recognized by cytosolic SecA. The
preprotein/SecB complex is targeted to SecA, which binds the signal sequence and
mature region of the preprotein and SecB. Upon interactions with the preprotein/SecB
complex as well as with the SecYEG translocon, SecA undergoes a dramatic
conformational change into the translocation-active form (Figure 3.1). This structural
rearrangement likely reveals a higher affinity signal sequence-binding site that is used as
a proofreading step prior to insertion of the precursor into the SecYEG translocon. SecA
correctly positions the preprotein and uses ATP hydrolysis for translocation through the
SecYEG channel (Clerico, 2008). Despite the vast amount of biochemical and
biophysical experiments performed to try to identify the signal sequence-binding site, its
exact location in both cytosolic and translocation-active SecA is still poorly defined.
Various biochemical methods have been used to try to determine the region where
signal sequences bind SecA. Kimura et al. (Kimura et al., 1991) first tried to try to
identify the signal sequence-binding site using the zero-length cross-linker, 1-ethyl-3-(3dimethylaminoproyl) carbodiimide (EDC), which couples carboxyl groups to primary
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Figure 3.1 Model for SecA-mediated translocation
The preprotein (pink) is translated by the ribosome nascent chain complex (RNC).
Tetrameric SecB (tan hexagons) binds the preprotein keeping it in an unfolded state.
SecA (green) interacts with the SecB/preprotein complex and binds to the SecYEG
translocon and undergoes a major conformational change. SecA binds the signal
sequence (red box) of the preprotein and positions the preprotein for translocation
through SecYEG.
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amines. Reconstituted SecA fragments were cross-linked to radio-labeled in vitro
translated preproteins. These experiments indicated that the preprotein cross-linked to the
N-terminal portion of SecA and demonstrated that residues 267-340 encompassed the
binding site.
Initial studies performed by our group, compared the binding of signal peptides to
full-length SecA and an activated form of SecA, SecA64, which is a 64 kD N-terminal
chymotryptic fragment generated in the presence of ATP. This experiment showed that
signal peptides bound more strongly to SecA64 than to full-length SecA (Triplett et al.,
2001). These results suggest that either the signal sequence-binding site is more
accessible in SecA64 or that the activated form of SecA has a different binding site.
Efforts to identify the signal sequence-binding site began in earnest when the first
crystal structure of SecA was solved by Hunt el al. (Hunt et al., 2002), a computer
program VOIDOO (Kleywegt and Jones, 1994) was used (Hunt et al., 2002) to detect
unknown grooves or cavities on the surface of the structure. Three regions were
identified as possible preprotein interactions sites: the CTL groove, the single-stranded
nucleic acids (SS-NA) groove, and the methionine canyon (Figure 3.2, A). Each of these
cavities is located at an interface between two or more domains. Binding of the signal
sequence of a preprotein to the CTL groove would require the displacement of the CTL
of SecA (Hunt et al., 2002). Previous studies have shown that SecB binds to the CTL of
SecA, and this likely disengages the CTL from the rest of the molecule (Dempsey et al.,
2004). Our group previously reported (Chou and Gierasch, 2005) the structure of the
signal peptide bound to SecA and proposed a binding site in the same region as the CTL
groove (Figure 3.2, B, red and green), which has both electrostatic and hydrophobic
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Figure 3.2 Proposed signal sequence binding regions
A. Surface and cartoon representation of the B.subtilis SecA crystal structure (Hunt et al.,
2002) (1M6N) color-coded for the different domain: blue, first nucleotide binding fold
(NBFI); yellow, preprotein cross-linking domain (PPXD); purple, second nucleotide
binding fold (NBFII); green, α-helical scaffold domain (HSD); orange, α-helical wing
domain (HWD); and red, carboxyl-terminal linker (CTL). The black boxes indicate the
location of possible ligand-binding sites, CTL groove, single-stranded nucleic acids (SSNA) groove, and methionine canyon. B. Monomeric B.subtilis SecA crystal structure
(Osborne et al., 2004) (1TF5) surface and cartoon representation color-coded for
proposed signal sequence binding regions: red, Chou and Gierasch, 2005 (Chou and
Gierasch, 2005); blue, Papanikou et al., 2005 (Papanikou et al., 2005); green, overlap
between the latter two sites; cyan, Musial-Siwek et al., 2007 (Musial-Siwek et al., 2007);
yellow, Osborne et al., 2004 (Osborne et al., 2004). C. Cartoon and surface representation
of the E. coli SecA NMR structure (Gelis et al., 2007) (2VDA) color-coded for domains
as described above. The modeled signal peptide is shown in cyan. D. Structure of SecA
from T. maritima represented by surface and cartoon bound to SecYEG (not shown)
(Zimmer et al., 2008) (3DIN). The arrow represents the clamp region proposed to be a
potential signal sequence binding site.
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character. SecA has structural homology to helicases, and the proposed SS-NA groove is
analogous to the site where nucleic acids interact with helicases. The methionine canyon
at the interface between NBF II and the N-terminal HSD has weakly packed Met residues
(Hunt et al., 2002). In SRP the signal sequence has been shown to interact with the Metrich M-domain (Zopf et al., 1993), which has a hydrophobic groove lined with Met
residues (Bernstein et al., 1989). All of these potential interaction sites are located within
the first two-thirds of the SecA molecule, which is consistent with the finding that signal
peptides interact with SecA64 (Triplett et al., 2001).
In another study, Economou and co-workers (Baud et al., 2002) used chemical
cross-linking with dithiobis(succinimidyl propionate) to demonstrate that a synthetic
alkaline phosphatase signal peptide interacts with N-terminal fragments of SecA
containing the first 263 residues. They further showed by deletion analysis that residues
219-244 are essential for signal peptide binding but residues 234-263 may be needed for
optimal signal sequence-binding (Baud et al., 2002). This proposed binding region is
located in the preprotein cross-linking domain (PPXD), which was so named from the
results presented in the original preprotein cross-linking study by Kimura et al. (Kimura
et al., 1991). These results were further supported by surface plasmon resonance assays,
which showed that several SecA modification including C-terminal truncation (residues
1-610), IRA1 deletion (Δ783-795) (for further discussion of IRA1, see Chapter 1), or
mutation of Trp775 to Ala, increase binding to the immobilized signal peptide when
compared to wild-type SecA (Vrontou and Economou, 2004). These results indicate that
IRA1 may be acting as a molecular switch to regulate signal sequence binding (Baud et
al., 2002). This group also studied the PPXD in isolation as well as various SecA deletion

103

mutants to determine if the PPXD could bind both the signal peptide and the mature
region of the preprotein. They found that signal peptides can bind directly to the isolated
PPXD and stabilize this domain in a distinct conformation (Papanikou et al., 2005).
The PPXD can be further broken down into two subdomains, the stem (residues
219-240 and 362-377) and the bulb (residues 234-361). Through protease protection
assays using either a signal sequence or a mature region of a preprotein, signal sequences
were shown to bind to the stem region (Figure 3.2, B, blue and green) while the mature
region of the preprotein can bind to the bulb (Papanikou et al., 2005). This potential
signal sequence binding to the stem region consistent with to the CTL groove proposed in
by (Hunt et al., 2002) when the first crystal structure of SecA was solved.
In 2004 Rapoport and co-workers (Osborne et al., 2004) solved the crystal
structure of a monomeric version of SecA. In this structure, the PPXD has rotated and
moved away from the HWD creating a groove between these two domains. Based on this
structure, this group proposed two alternative preprotein binding grooves. Groove 1 is
located between the PPXD and HWD and is lined with several polar and charged residues
(Figure 3.2, B, yellow). The second proposed site, groove 2, overlaps with the signal
sequence-binding site proposed by several other groups (Figure 3.2, B, blue, green, and
red) (Papanikou et al., 2005; Chou and Gierasch, 2005; Hunt et al., 2002).
In order to determine the region important for signal sequence-binding, MusialSiwek et al. (Musial-Siwek et al., 2005) monitored signal peptide binding to SecA by
fluorescence resonance energy transfer (FRET). In this case, the intrinsic Trp residues of
SecA were used as the donor, and the alkaline phosphatase signal sequence synthesized
with a C-terminal Cys, which was labeled with IAEDANS, served as the acceptor. Using

104

this system they were able calculated that c-SecA has one signal sequence-binding site
with a Kd of 2.4 µM but in lipid vesicles the binding fit best to a two-state model with a
Kd1 of 0.9 µM and Kd2 of 11.2 µM. By Trp mutagenesis, they observed that Trp 349
appears to contribute the most to the FRET signal but Trp 775 also appears to play a role.
They also observed that mutations to residues in the third helix of the PPXD also
decreased FRET efficiency, indicating that this region may be important for signal
sequence-binding. Subsequently, this same group performed cross-linking studies using a
synthetic alkaline phosphatase signal peptide. At the end of the h-region of the signal
peptide, benzoylphenylalanine was incorporated as a photoactivatable cross-linker and
the C-terminal Cys labeled with biotin. At various regions throughout the SecA protein
they incorporated Factor Xa cleavage sites to specifically cleave SecA into two parts.
Through cross-linking of the signal peptide to the various SecA mutants, digesting with
Factor Xa, and detecting of the biotin, they observed cross-linking to residues 269-322
(Figure 3.2, B, cyan), (Musial-Siwek et al., 2007) which is similar to the site identified by
Kimura (Kimura et al., 1991).
Recently, an NMR structure of the SecA homodimer was determined using a
domain-parsing strategy in conjunction with specific labeling of the methyl groups of Ile,
Leu, Val, and Met (Gelis et al., 2007). To determine the structure of the complex between
c-SecA and the signal sequence, Cys mutants of the KRRLamB signal peptide were
labeled with a nitroxide spin label. Using methyl-TROSY experiments, the distancedependent broadening of the NMR signals by the nitroxide-labeled signal peptide were
obtained. Changes in the methyl resonance intensities of SecA in the presence of the
signal peptide were converted to distances. From these distance constraints, models of
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signal peptide bound to SecA were generated. The orientation of the signal peptide bound
to SecA was determined by labeling the signal peptide with nitroxide at two different
positions, before and after the hydrophobic core. The proposed binding site on SecA is
the groove between the PPXD and HWD with the signal peptide interacting
predominantly with the PPXD (Figure 3.2, C). The groove has both hydrophobic and
electrostatic components (Gelis et al., 2007). This site is not accessible in the original
crystal structure because the PPXD packs against the HWD (Hunt et al., 2002) (Figure
3.2, A). In the monomeric version of B. subtilis SecA (Osborne et al., 2004) and as well
as the NMR structure (Gelis et al., 2007), the PPXD has rotated slightly and moved so
there are no interactions with the HWD (Figure 3.2, C). This binding region modeled
from the NMR distance restraints (Gelis et al., 2007) and the site determined by the
FRET and cross-linking studies (Musial-Siwek et al., 2005; Musial-Siwek et al., 2007)
are in similar regions on the PPXD. This region also has some overlap with the stem
region (residues 219-240 and 362-377) (Papanikou et al., 2005) as well as groove 1 from
the monomeric crystal structure (Osborne et al., 2004) (Figure 3.2).
All of the signal sequence-binding studies except for Musial-Siwek et al. (MusialSiwek et al., 2007) have been performed on the cytoplasmic form of SecA, which is not
the conformation involved in the translocation reaction (see the introduction to Chapter 2
for a detailed description). A new low resolution structure of truncated SecA bound to the
SecYEG translocon has recently been solved (Zimmer et al., 2008) and may provide a
framework for signal sequence binding to SecA. From this structure, a new preprotein
binding site was proposed. In this SecA structure, the PPXD has rotated even further
away from the HWD and makes contact with both SecY and NBF I. The PPXD, NBF II,
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and portions of the HSD form a new ‘clamp’ region, which is lined with conserved
residues some of which forms a hydrophobic patch (Figure 3.2, D). This region could be
used to recognize the signal sequence and position the preprotein above the SecY pore
(Zimmer et al., 2008). A previous study (Cooper et al., 2008) using site-directed spin
labeling with electron paramagnetic resonance (EPR) spectroscopy with SecA,
preproteins, and inverted membrane vesicles supports the preprotein interactions with the
‘clamp’ region.
Although a significant amount of work has been performed to identify the signal
sequence-binding site on SecA, the location of the site is still unclear especially in the
translocation-active form. Nearly all of the studies have been performed on the cytosolic
form of SecA, which is likely not to be the physiologically relevant form of the protein
needed for signal sequence binding. Identifying the signal sequence-binding site on the
membrane- or translocon-bound form of SecA has been difficult due to the presence of
liposomes and other components of the secretory pathway. This chapter describes signal
sequence interactions with c-SecA and u-SecA, a soluble translocation-active form of
SecA, as well as cross-linking studies to define the signal sequence-binding region on
both forms. A possible signal sequence recognition mechanism is proposed based on the
results and the recently published SecA/SecYEG crystal structure (Zimmer et al., 2008).

3.2.

Experimental strategy
In Chapter 2, we established that low concentrations of urea convert SecA to a

state (u-SecA) that mimics the translocation-active form of full-length SecA. U-SecA
thus provides a system to determine the signal sequence-binding site on the translocation-
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active form of SecA. To gain further insights into the translocation mechanism, the signal
sequence-binding site on both the cytosolic and translocation-active forms of SecA must
be determined. We have developed a powerful strategy using photoactivatable crosslinking in conjunction with limited proteolysis, two-dimensional gels, biotin and regionspecific SecA antibody detection to map the signal peptide binding region on both cSecA and u-SecA.
In our strategy, the N-terminal biotinylated modified LamB signal peptide, BioKRRLamB19C, was labeled with the photoactivatable cross-linker 4-maleimidobenzophenone. The biotin on the signal peptide allows for the specific detection of only
the cross-linked products. As shown in Chapter 2, c-SecA is relatively resistant to
protease digestion. In order to compare the cross-linking patterns between c-SecA and uSecA, c-SecA was first cross-linked to signal peptide (Figure 3.3 (A1)) followed by
incubation in urea in the same conditions that were used to generate u-SecA (A2) before
proteolysis. This enables the cross-linking to occur in the c-SecA form but leads to the
same conditions for limited chymotrypsin digestion (A5). U-SecA was generated as
described in Chapter 2 (A3), cross-linked to signal peptide (A4), and subjected to limited
protease digestion (A5).
Due to the large size of the SecA protein, numerous chymotryptic cleavage sites
are anticipated. SecA has 40 potential digestion sites predicted from ExPASy (Gasteiger
et al., 2005) with a probability threshold set at 80% based on enzyme specificity for the
surrounding sequence. Chymotrypsin preferentially digests at aromatic residues, and the
probability of cleavage is based upon the type of amino acid in the sequence before and
after the preferred aromatic residue (Keil, 1992). Therefore, chymotrypsin digestion may

108

Figure 3.3 Experimental design and data analysis
Flow charts of the experiment design for the 2-D gels and for how the data from the 2-D
gels was processed.

109

110

generate several different proteolytic SecA fragments of similar molecular weight. This
complexity of the SecA digestion pattern makes antibody mapping by one-dimensional
SDS-PAGE difficult to resolve.
To circumvent this problem, cross-linked SecA fragments were analyzed by twodimensional gel electrophoresis. The first dimension is isoelectric focusing (IEF), which
separates fragments based on their isoelectric point (Figure 3.3 (A6)), and the second
dimension is molecular weight separation by SDS-PAGE (A7). This powerful technique
with antibody mapping enabled the identification of different SecA domains involved in
binding of signal sequences (A9, A10). The analysis of the two-dimensional gels for
cross-linked proteins by biotin detection and antibody mapping is not trivial. Manual
analysis of the biotin detection (Figure 3.3, (B1)) of the two-dimensional gels was
performed to compare the pattern of cross-linked fragments between c-SecA and u-SecA
(B2) and differences in the cross-linking pattern were identified (B3). The identities of
the cross-linked SecA fragments were manually assigned using the SecA region-specific
antibody data (B4) and the identifications of the cross-linked fragments from c-SecA and
u-SecA were compared (B5). Using the mass spectrometry results of the chymotrypsin
SecA fragments from Chapter 2, we were able to identify the cross-linked SecA
proteolytic fragments (Figure 3.4, A). This powerful approach has enabled us to
determine the signal sequence-binding region on both the soluble and translocation-active
forms of SecA.
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Figure 3.4 Map of chymotrypsin cleavage sites
Based on the surface accessibility of the aromatic residues and mass spectrometry results
from Chapter 2, the chymotrypsin cleavage sites are shown. The linear sequence of SecA
is color-coded for the different domains and the region-specific antibodies are indicated
above the cartoon. The relative cleavage at each site is indicated by the thickness of the
arrow. B. The cartoons illustrate the different proteolytic fragments of SecA cross-linked
to signal peptide in the 2-D gels. The SecA cross-linked fragments are broken down into
three subsets based on domains. The name of each fragment is indicated on top of the
cartoon.
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3.3.

Results

3.3.1. Establishing the validity of the SecA-signal peptide interaction
Although signal peptide binding to c-SecA has previously been established (Gelis
et al., 2007), we needed to confirm that signal peptides bind to u-SecA in a specific
manner. Due to the complications of working with the highly hydrophobic signal peptide
and working in urea solutions, typical binding assays were unsuccessful so we developed
a qualitative gluteraldehyde cross-linking based binding assay. This method uses
gluteraldehyde to cross-link a biotinylated KRRLamB19C signal peptide (Figure 1.2, B)
to c-SecA and u-SecA. Therefore, if the signal peptide is bound to either conformation of
SecA, the protein and signal peptide will be cross-linked upon addition of glutaraldehyde.
The cross-linked samples were run on tricine SDS-PAGE gels and transferred to a
PVDF membrane. The biotin signal from the signal peptide was detected by streptavidinhorseradish peroxidase (HRP). Only cross-linked SecA protein, which migrated around
100 kD for the monomer or about 200 kD for the dimer are detected by streptavidin-HRP.
In this set of experiments, the amount of Bio-KRRLamB19C signal peptide was held
constant while the concentration of c-SecA or u-SecA was increased. For both forms of
SecA, the biotin signal increased as the concentration of protein was increased (Figure
3.5). As shown in Chapter 2, c-SecA is predominantly in a dimeric form but in this signal
peptide binding assay the small amount of monomeric c-SecA also binds signal peptide
(Figure 3.5, A, B). This is likely to be a non-specific binding event since the signal of the
monomer does not increase as the protein concentration is increased.
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Figure 3.5 Signal peptide binding assay
Gluteraldehyde cross-linking was used to assess if either form of SecA can bind a
biotinylated signal peptide. A. Biotin detection (top) and Coomassie blue stained SDSPAGE gel (bottom) of increasing concentrations of c-SecA cross-linked to 1.0 µM BioKRRLamB19C signal peptide. The c-SecA concentrations in the lanes are as follows: (1)
0.13 µM, (2) 0.21 µM, (3) 0.44 µM, (4) 0.49 µM, (5) 0.61 µM, (6) 0.87 µM, (7) 1.0 µM,
(8) 1.41 µM, (9) 1.81 µM. Dimeric SecA migrates at 204 kD while monomeric SecA
migrates at 102 kD. B. Quantitation of the biotin signal from two different experiments.
Due to variation in the protein concentrations only six concentrations are shown. Dimeric
SecA is shown by the red bars while monomeric SecA is shown by the blue bars. C.
Biotin detection (top) and Coomassie blue stained SDS-PAGE gel (bottom) of increasing
concentrations of u-SecA cross-linked to Bio-KRRLamB19C signal peptide. The u-SecA
concentrations in the lanes are as follows: (1) 0.01 µM, (2) 0.14 µM, (3) 0.41 µM, (4)
0.68 µM, (5) 1.0 µM, (6) 1.25 µM, (7) 1.29 µM, (8) 1.47 µM, (9) 1.63 µM. Dimeric
SecA migrates at 204 kD while monomeric SecA migrates at 102 kD. D. Quantitation of
the biotin signal from two different experiments. Due to variation in the protein
concentrations only six concentrations are shown. . Dimeric SecA is shown by the red
bars while monomeric SecA is shown by the blue bars.

115

(µM)

(µM)

116

In u-SecA most of the signal peptide binds to the monomer but as the total protein
concentration increases more dimer is present (Figure 3.5, C, D). The titrations cannot be
performed at higher protein concentrations because c-SecA forms higher oligomers (Shin
et al., 2006) and u-SecA begins to aggregate non-specifically. In both cases, the
functional form, dimer for c-SecA and monomer for u-SecA, appears to saturate around a
protein concentration of one µM. This qualitative value is comparable to binding
affinities previously reported. (Musial-Siwek et al., 2005; Gelis et al., 2007). We
concluded that signal peptide binds to both c-SecA and u-SecA with similar affinities.
This result was surprising at first because previous work showed that an activated form of
SecA, SecA64, which lacks the C-terminal one-third of the protein, bound signal peptides
better than full-length c-SecA (Triplett et al., 2001). Therefore, u-SecA in which the Cterminal portion has undergone domain dissociation might also have been expected to
bind signal peptides with a higher affinity. However, u-SecA is generated by low
concentrations of urea, and besides pushing SecA into the activated form, the urea could
also weaken signal peptide binding. Urea weakens non-covalent interactions and since
signal sequence recognition is mediated through hydrophobic interactions, the binding
affinity to u-SecA is likely decreased. In the case of c-SecA, part of the signal peptide
adopts a helical conformation upon binding (Chou and Gierasch, 2005; Gelis et al., 2007)
and in u-SecA the helical structure may be disrupted resulting in a decreased binding
affinity.
To test the specificity of c-SecA and u-SecA signal peptide interaction, a
qualitative competition assay similar to the assay as described above was performed. The
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concentration of both forms of SecA and the Bio-KRRLamB19C peptide was held
constant at 1 µM and increasing amounts of the non-biotinylated signal peptide,
KRRLamB WT (Figure 1.2, B), were added as a competitor. If the binding of the
biotinylated signal peptide is specific, it should be displaced from SecA with the addition
of the non-biotinylated signal peptide and result in a decrease in the biotin signal.
For c-SecA, the non-biotinylated signal peptide starts to compete with the
biotinylated peptide to a small degree with equimolar amounts. When 20-fold excess
KRRLamB WT is added, a little less than three-quarters of the biotinylated peptide is
displaced (Figure 3.6, A, B). The concentration of signal peptide cannot be increased
beyond 20-fold excess because it starts to induce higher oligomers/aggregation of cSecA. The competing peptide was equilibrated with the c-SecA for one minute because
longer equilibration times showed little differences in the biotin signal. This suggests that
the biotinylated form of the signal peptide may have a slightly higher affinity for c-SecA
than the non-biotinylated form as well as has a relatively fast on/off rate.
In the case of u-SecA, the equimolar amount of non-biotinylated signal peptide
competes off about one-quarter of the biotinylated signal peptide. By 15-fold excess of
the non-biotinylated signal peptide, more than three-quarters of the biotin signal has
disappeared indicating that a majority of the biotinylated signal peptide has been
displaced (Figure 3.6, C, D). If higher concentrations of signal peptides are used, u-SecA
is pushed into the dimeric and aggregated forms. This dimerization/aggregation
phenomenon with monomeric u-SecA is similar to SecA that was monomerized by
phospholipid analogs. Monomeric SecA associated to the phospholipids is also
dimerized/polymerized with the addition of high concentrations of signal peptide
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Figure 3.6 Signal peptide competition assay
Competition between biotinylated signal peptide and non-biotinylated signal peptide was
monitored by gluteraldehyde cross-linking. A. Biotin detection (top) and Coomassie blue
stained SDS-PAGE gel (bottom) of increasing concentrations of the competing
KRRLamB WT signal peptide cross-linked to 1.0 µM each c-SecA and BioKRRLamB19C signal peptide. The KRRLamB WT concentrations in the lanes are as
follows: (1) 0 µM, (2) 1.0 µM, (3) 2.5 µM, (4) 5.0 µM, (5) 10.0 µM, (6) 12.5 µM, (7)
15.0 µM, (8) 17.5 µM, (9) 20.0 µM. Dimeric SecA migrates at 204 kD while monomeric
SecA migrates at 102 kD. B. Quantitation of the biotin signal in A based on three
separate experiments. Dimeric SecA is shown by the red bars while monomeric SecA is
shown by the blue bars. C. Biotin detection (top) and Coomassie blue stained SDS-PAGE
gel (bottom) of increasing concentrations of the competing KRRLamB WT signal peptide
cross-linked to 1.0 µM each u-SecA and Bio-KRRLamB19C signal peptide. The
KRRLamB WT concentrations in the lanes are as follows: (1) 0 µM, (2) 1.0 µM, (3) 2.5
µM, (4) 5.0 µM, (5) 10.0 µM, (6) 12.5 µM, (7) 15.0 µM. Dimeric SecA migrates at 204
kD while monomeric SecA migrates at 102 kD. D. Quantitation of the biotin signal in C
based on two separate experiments. Dimeric SecA is shown by the red bars while
monomeric SecA is shown by the blue bars.
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(Benach et al., 2003). For u-SecA the competing signal peptide needed to be equilibrated
with u-SecA for one hour prior to cross-linking otherwise little competition was
observed. This observation suggests that the signal peptide has a slow off-rate from uSecA.
Due to the highly hydrophobic nature of the signal peptide, it is not surprising that
all of the biotinylated signal peptide is not displaced in the competition assay. There is
likely to be some level of non-specific interaction between SecA and the signal peptide
that cannot be competed off of SecA in the gluteraldehyde cross-linking assay. Overall,
these results demonstrate that c-SecA and u-SecA directly and specifically bind signal
peptide.

3.3.2. Analysis of SecA fragments cross-linked to signal peptide
In order to determine the signal sequence-binding region on c-SecA and u-SecA,
we employed a photoactivatable cross-linking approach. The Bio-KRRLamB19C signal
peptide was labeled with 4-maleimido-benzophenone. Irradiation with UV light leads to a
benzophenone diradical that has the ability to abstract a hydrogen atom from a nearby
electron-rich σ-bond and upon recombination, forms a covalent linkage. If no suitable
bond is present the diradical reacts with water making benzophenone (BP) a highly
specific cross-linking reagent (Dorman and Prestwich, 1994).
To discern if the signal sequence-binding site is different in c-SecA and u-SecA,
we developed a strategy to compare the cross-linked proteolytic fragments of both forms
of SecA (Figure 3.3, A (1-5)). This strategy enables us to determine differences in the
cross-linking pattern between c-SecA and u-SecA. Any differences can be attributed to
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alternative cross-linking and not differences in protease digestion between the two
different conformations of SecA.
In our initial studies, cross-linked proteins, c-SecA (Figure 3.7) and u-SecA
(Figure 3.8), were subjected to limited chymotrypsin digestion over a time course ranging
from 10 sec to 10 min. The digests were separated on tricine SDS-PAGE gels and
analyzed by biotin and SecA region-specific antibody detection. The overall pattern of
digestion, biotin, and antibody detection between c-SecA and u-SecA is similar but there
are differences in the lower molecular weight bands in the biotin detection. The two
minute time point of digestion (Figure 3.9) shows the biotin detection of SecA fragments
around 66 kD corresponds to the A1, A2, A3, and A4 antibodies (see Chapter 2, Figure
2.8), which represents the N-terminal two-thirds of the protein as previously
demonstrated with SecA64. A smaller proteolytic fragment of about 45 kD is recognized
by the A1 and A2 antibodies. These cross-linked SecA fragments are present in both cSecA and u-SecA. Smaller molecular weight bands, approximately 30 and 20 kD are
detected only in u-SecA. The antibodies that correspond to these bands are A5 and A6 for
the 30 kD band and A3 and A4 for the 20 kD band (Figure 3.9, B red boxes). SecA has
40 potential chymotrypsin digestion sites (calculated from ExPASy with a threshold set at
75% (Gasteiger et al., 2005)) so several different proteolytic fragments of similar
molecular weight can be generated. Therefore, mapping the identity of the cross-linking
fragments by 1-D gel antibody detection is difficult.
SecA is an acidic protein with a theoretical isoelectric point (pI) of 5.43
(calculated from ExPASy) (Gasteiger et al., 2005). To further separate and identify the
cross-linked SecA fragments, we chose to use two-dimensional gels. Isolectric focusing
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Figure 3.7 Limited protease digestion of signal peptide cross-linked to c-SecA
Cross-linking was were performed as c-SecA but then incubated in 2.2 M urea for four
hours to have a similar chymotrypsin pattern as u-SecA. The lanes are as follows: (1) no
digestion, (2) 10 sec, (3) 1 min, (4) 2 min, (5) 3 min, (6) 4 min, (7) 5 min, (8) 10 min. The
labels of the different panels correspond to the different antibodies (A1 – A6), Coomassie
blue stain (C) and Biotin detection (B). The molecular weight standard is indicated to the
left of the Coomassie blue stained gel. A control of chymotrypsin alone was also included
in the experiment but did not react with any of the detection methods so it is not shown.
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Figure 3.8 Limited protease digestion of signal peptide cross-linked to u-SecA
After incubated in 2.2 M urea for four hours to generate u-SecA, cross-linking was
performed followed by protease digestion. The lanes are as follows: (1) no digestion, (2)
10 sec, (3) 1 min, (4) 2 min, (5) 3 min, (6) 4 min, (7) 5 min, (8) 10 min. The labels of the
different panels correspond to the different antibodies (A1 – A6), Coomassie blue stain
(C) and Biotin detection (B). The molecular weight standard is indicated to the left of the
Coomassie blue stained gel. A control of chymotrypsin alone was also included in the
experiment but did not react with any of the detection methods so it is not shown.
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Figure 3.9 Bio-KRRLamB19C-MBP cross-linking to both c-SecA and u-SecA
A. The two minute time point from c-SecA limited protease digestion. The molecular
weight marker is shown on the left and each lane is labeled with the corresponding
detection, A1 – A6 antibodies, biotin detection (B), and Coomassie blue stain (C). B. The
two minute time point from u-SecA limited protease digestion. The molecular weight
marker is shown on the left and each lane is labeled with the corresponding detection as
described above. The red boxes indicate biotin detected fragments that are only found in
u-SecA.
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(IEF) was performed using pH 4-7 IEF strips (Figure 3.3, (A6)). After IEF the SecA
fragments were further separated by tricine SDS-PAGE (A7). The 2-D gels were
transferred to polyvinylidene fluoride (PVDF) membrane (A8) for biotin (A9) and
region-specific antibody (A10) detection.
We analyzed the 2-D biotin detection of c-SecA and u-SecA blots (Figure 3.10)
for cross-linked SecA fragments (Figure 3.3 (B1)) as described in the Materials and
Methods. Only SecA fragments smaller than 50 kD were analyzed. Out of 21 potential
fragments found on each blot, 12 fragments in c-SecA (Figure 3.11 A) and 18 fragments
in u-SecA (Figure 3.11 C) were calculated to be above background signal (see Materials
and Methods for description). The intensity of each spot was quantified (Figure 3.11 B,
D) using ImageJ software (Abramoff et al., 2004) normalizing the data to the free signal
peptide found at the bottom of both blots.
C-SecA (Figure 3.11 A) and u-SecA (Figure 3.11 B) biotin detection blots were
aligned using the Flicker software (Lemkin et al., 2005). Since focusing differences can
arise during IEF, the Flicker software enables the alignment of two different gels as
described in the Material and Methods. Flickering between the two gel images allows for
visualization of overlapping cross-linked fragments in c-SecA and u-SecA. Several SecA
fragments are the same in both biotin detections (S1-S13) but some of these fragments
(S8-S11 and S13) were observed in c-SecA but were not above background signal to be
defined as a fragment. In addition to having similar proteolytic fragments, three unique
fragments in c-SecA, C1-C3, and five unique fragments in u-SecA, U1-U5 were found
(Figure 3.11).
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Figure 3.10 2-D gel biotin detection of signal peptide cross-linked to c- and u-SecA
Bio-KRRLamB19C-MBP signal peptide was cross-linked to both c-SecA and u-SecA
followed by digestion with chymotrypsin for two minutes. The digestions were separated
by isoelectric focusing, 4-7 pH range, followed by molecular weight separation with 8%
SDS-PAGE gels. A. Biotin detection of c-SecA proteolytic fragments. Yellow circles
indicate potential spots (see materials and methods for spot determination). B. Same as in
A but with u-SecA and orange circles indicating potential spots.
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Figure 3.11 Analysis similar and different fragments in c- and u-SecA
A. The biotin detection of 2-D gel for cross-linked c-SecA. Spots that are similar to uSecA are S1-S12 and spots that are different are C1-C3. Not all of the similar spots in cSecA are above background. B. Quantitation of the spots shown in A using the ImageJ
software. Each spot was measured for biotin signal three times. C. The biotin detection of
2-D gel for cross-linked u-SecA. Spots that are similar to c-SecA are S1-S13 and spots
that are different are U1-U5. D. Quantitation of spots shown in C. Each spot was
measured for biotin signal three times.
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After biotin detection, each blot was probed with the different region-specific
SecA antibodies. This enables the putative mapping of SecA fragments that are crosslinked to signal peptide. Both the biotin and antibody probes were performed on the same
blot, thus, allowing for the biotin probed gel to be aligned separately with each of the
antibody detections using the Flicker software (Lemkin et al., 2005). The flickering
between the two images enabled visualization of overlaying fragments between the biotin
and antibody images. From this method, the SecA domain corresponding to the
proteolytic fragment was determined. One striking feature that is apparent when
comparing the biotin detection to the antibody detection is that the cross-linking is
amazingly specific. Only a small subset of the all SecA proteolytic fragments were crosslinked to the signal peptide.
All the similar cross-linked fragments in c-SecA (Figure 3.12) and u-SecA
(Figure 3.13) are recognized by exactly the same antibodies with the exception of the
S12. This fragment was only recognized by the A4 antibody in c-SecA but was identified
by the A3 and A4 antibodies in u-SecA. Using the mass spectrometry data from Chapter
2 and the antibody detection data, we were able to determine the SecA chymotryptic
fragments that were cross-linked to signal peptide (Figure 3.4, B). One subset of
fragments represents cross-linking to the NBF I and PPXD domains of SecA. The S1-S5
and S7-S8 fragments are recognized by the A1 and A2 antibodies. S1, S2, and S3
fragments, about 40 kD in size, have slightly different isoelectric points (Figures 3.12 and
3.13). These SecA proteolytic fragments represent residues 11-405 (Figure 3.4 B) but
have different cleavage sites a few residues away at one or both of the termini. The S4
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Figure 3.12 Antibody detection of 2-D gels of c-SecA cross-linked to signal peptide
2-D gels were detected for biotin (B) and with the region-specific antibodies. The
digested 1-D sample stained with Coomassie blue (C) with the molecular weights is
shown to the left of the biotin image. The pH range for the IEF is shown on the top of the
images. The lane on the left side of the image is cross-linked c-SecA sample that was not
subjected to IEF. The yellow circles indicate the positions of the different SecA
proteolytic fragments identified in the biotin image.
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Figure 3.13 Antibody detection of 2-D gels of u-SecA cross-linked to signal peptide
2-D gel were detected for biotin (B) and with the region-specific antibodies. The digested
1-D sample stained with Coomassie blue (C) with the molecular weights is shown to the
left of the biotin image. The pH range for the IEF is shown on the top of the images. The
lane on the left side of the image is cross-linked u-SecA sample that was not subjected to
IEF. The yellow circles indicate the positions of the different SecA proteolytic fragments
identified in the biotin image.
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and S5 fragments are approximately 24 kD in size and represent smaller proteolytic
fragments of S1, S2, or S3. S4 and S5 include amino acids 80-299 and one of the
fragments has a slightly different cleavage site resulting a different isoelectric point. S7,
about 20 kD in size, and S8, approximately 17 kD, are two further proteolytic cleavages
of the S1-S3 fragments (Figure 3.4, B). S7 is only detected by the A1 antibody while S8
is exclusively detected by A2.
Another subset of similar SecA proteolytic fragments cross-linked to signal
peptide in both c-SecA and u-SecA maps to NBF II. The approximately 19 kD S12
fragment is recognized by the A3 and A4 antibodies and includes residues 406-598. A
second fragment, S13, is eight kD and has been further proteolyzed from the S12
fragment. One other cross-linked fragment is the same in c-SecA and u-SecA belongs to
the third subset, the HSD and HWD. S6 is about 20 kD and is recognized only by the A5
antibody. This fragment includes residues 623-794 (Figure 3.4, B)
Several biotin-detected fragments are specific for c-SecA and u-SecA. The three
unique fragments found in c-SecA (Figure 3.12) belong to the NBF II subset. The larger
C2 and C3 fragments, approximately 43 kD, are recognized by the A2, A3, and A4
antibodies and correspond to residues 300-691. C2 and C3 are similar in molecular
weight but differ slightly in isoelectric point indicating a small difference in digestion. A
smaller unique c-SecA cross-linked fragment, C1 about 19 kD, represents a proteolytic
fragment from C2 or C3. C1 is very similar to S12 but has a different isolectric point due
to a different chymotrypsin cleavage site.
In u-SecA five unique cross-linked fragments are observed (Figure 3.13) but only
three of the five fragments were identified by antibody mapping. The two unidentified
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fragments have low biotin signal (Figure 3.11, D) and probably do not contain enough
SecA protein to be detected by the antibodies. The U1 fragment is in the NBF I and
PPXD cross-linking subset. U1 is similar to S1, S2, S3 in molecular weight, isoelectric
point, and antibody detection. Therefore, U1 is similar to the S1, S2, and S3 fragments
but has a slightly different chymotrypsin digestion site. The U2 fragment is a member of
the NBF II subset and is roughly 15 kD. This fragment is exclusively recognized by the
A3 antibody and represents amino acids 406-541. U2 is very similar to S12 and S13
fragments and is a further proteolytic fragment of S12. The third u-SecA specific crosslinked fragment is part of the HSD and HWD subset. U4 is about 15 kD, recognized by
A5 antibody, and corresponds to residues 623-762. This fragment is a smaller proteolytic
piece from the S6 fragment.
These results demonstrate that c-SecA and u-SecA share the same signalsequence binding site. Signal peptide cross-linking is observed to three regions of the
protein indicating that the binding region is at the interface between NBFI, NBFII,
PPXD, and N-terminal HSD.

3.4.

Discussion
The mechanistic details of preprotein translocation through the SecYEG

translocon by SecA are poorly understood. Activation of SecA by the addition of low
concentrations of urea has provided us with a soluble translocation-active form with
which to examine a critical step in the translocation process, signal sequence recognition.
Several previous studies have probed signal sequence binding to the cytosolic form of
SecA (Kimura et al., 1991; Triplett et al., 2001; Hunt et al., 2002; Baud et al., 2002; Chou
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and Gierasch, 2005; Papanikou et al., 2005; Gelis et al., 2007) but only one study by
Musial-Siwek et al. (Musial-Siwek et al., 2007) has tried to identify the signal sequencebinding site on an activated form of SecA. This group performed cross-linking studies in
lipid vesicles but based on its ATPase rate lipid-bound SecA is not in the same
conformation as translocation-active SecA (Lill et al., 1990).
These data argue that the signal sequence-binding site is located at the interface
between NBF I, NBF II, PPXD, and HSD domains, which maps to an area similar to the
‘clamp’ region proposed by Rapoport et al. (Zimmer et al., 2008) in their recent crystal
structure of truncated SecA bound to SecYEG. This result is in conflict with previously
determined signal sequence-binding sites (Musial-Siwek et al., 2007; Gelis et al., 2007).
We used benzophenone-mediated (BPM) cross-linking combined with limited
chymotrypsin digestion in conjunction with biotin and antibody detection to map the
signal sequence-binding site. Due to the heterogeneous nature of the different proteolytic
fragments of SecA, 2-D gels enabled us to examine SecA fragments of similar molecular
weight since fragments are separated by IEF as well as molecular weight.
The length of the maleimido-benzophenone cross-linker from the backbone of the
residue to which it is attached to the end of the benzophenone (BP) moiety is 12 Å. BP
can cross-link to electron-rich σ bonds in the side chains Leu, Val, Arg, and Lys (Dorman
and Prestwich, 1994) but is most likely to cross-link to Met (Wittelsberger et al., 2006).
To correlate our BPM cross-linking data to the NMR model of signal peptide bound to
SecA, all of the favorable cross-linking residues within 20 Å of Met 19 in the NMR
structure were examined. From this analysis, cross-linked SecA fragments should be
recognized predominantly by the A1, A2, and A5 antibodies. In the 2-D gel analysis,
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proteolytic fragments are strongly recognized by the A1, A2, A3, and A4 antibodies. Two
fragments, S6 and U4, are recognized by the A5 antibody and both fragments have a low
biotin signal meaning that this was not a predominant cross-linking site. One possibility
for the lack of cross-linking to the HWD (A5 antibody recognition) is that the orientation
of the signal peptide does not allow for cross-linking to this region but if the NMR model
is correct then we should only have cross-linking to SecA fragments recognized by the
A1 and A2 antibodies. An alternative explanation is that the fragments recognized by the
A3 and A4 antibodies are rich in surface-exposed Met residues, a favored cross-linker for
BP. All of the surface-accessible side chains of the Met from residues 351 to 664 in the
NMR structure were examined and only two surface-exposed Met were found. Both of
these Met are a great distance away from the region that was modeled to be the signal
sequence-binding site. Therefore, our data clearly suggest that the signal peptide is
binding in a different region than the one model by NMR or that there are actually two
signal sequence-binding sites.
The BPM cross-linking data from the 1-D gels showed differences in signal
peptide cross-linking to c-SecA and u-SecA. U-SecA has smaller molecular weight biotin
positive bands (Figure 3.9) despite both c-SecA and u-SecA being digested in the same
condition. Although unique c-SecA and u-SecA cross-linked fragments were present in
the biotin detection, further analysis shows that the unique fragments are similar to the
other identified S-fragments (Figure 3.4). This result demonstrates that c-SecA and uSecA share the same signal sequence-binding site.
Overall, u-SecA contains a greater number of unique biotin-positive fragments
and this could result from a difference in chymotrypsin digestion or more favorable
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cross-linking residues exposed to the signal peptide in the translocation-active form. A
difference in chymotryptic digestion can be ruled out since the digestion pattern and
relative band intensities in the Coomassie blue stained gels are identical for u-SecA and
c-SecA (Figure 3.9). The greater number of cross-links to u-SecA is likely due to more
favorable residues closer to the signal peptide. This suggests that the signal-sequence
binding groove in u-SecA has expanded. This would explain why some SecA natural
substrates such as LamB with the native signal sequence bind to cytosolic SecA with low
affinity but bind with high affinity to the activated SecA (Triplett et al., 2001).
Hunt et al. (Hunt et al., 2002) proposed the single-stranded nucleic acids (SS-NA)
groove (Figure 3.1 A) as a potential site for preprotein binding. The ‘SS-NA groove’
occupies the interface of NBF I, NBF II, PPXD, and HSD. This is consistent with our
data regarding the binding site for signal peptide in both c-SecA and u-SecA but in uSecA the domain dissociation causes the site to become extended. The ‘SS-NA groove’
in SecA is similar to other ssDNA grooves found in DNA helicases (Korolev et al., 1997;
Velankar et al., 1999), which have structural homology with the NBFs of SecA. Signal
sequence-binding to the SS-NA groove imply a molecular operate through a mechanism
similar to the helicases, such that the motor domains power the translocation of
preproteins in SecA as they unwinding of DNA in the helicases.
Based on our data, we propose a model where signal sequences bind to the SSNA region originally proposed by Hunt et al. (Hunt et al., 2002). The binding region is
the same in both the cytosolic and translocon-bound forms but in the latter form, the
binding region has been expanded which could allow for better signal sequence-binding.
This binding region is also in close proximity to the nucleotide-binding site. The signal
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sequence binding affinity can therefore be modulated by the presence of different
nucleotides in the binding pocket (Shin et al., 2006). Additionally, the signal sequence
can suppress the rate of ATPase activity as seen in the case of SecA64 (Triplett et al.,
2001). This SS-NA binding region is in a region similar to the clamp region proposed by
Zimmer et al. (Zimmer et al., 2008) based on the truncated SecA/SecYEG crystal
structure. Therefore, we propose a mechanism where the signal sequence binds to the SSNA groove and the mature portion of the preprotein binds to the PPXD. After the
proofreading step of signal sequence binding, ATP hydrolysis releases the signal
sequence and pushes it into the translocon.
During the course of this study, several experimental problems had to be resolved.
A critical experiment was verifying that u-SecA interacts with signal peptide in a specific
manner. This experiment was problematic do to the highly hydrophobic nature of the
signal peptide and the propensity of u-SecA aggregate at protein concentrations above 2.5
µM. Typical methods to assess binding such as size exclusion chromatography,
isothermal titration calorimetry, and equilibrium dialysis were unsuccessful. To
overcome this problem, we developed the qualitative gluteraldehyde cross-linking
binding assay. Although this assay does not provide a binding constant, we showed that
u-SecA indeed binds to signal peptide in a specific manner to further confirmed that uSecA is a translocation-active form of SecA.
Another major obstacle we overcame was determining the region on c-SecA and
u-SecA that was cross-linked to signal peptide. As shown in Chapter 2, c-SecA is less
proteolytically labile than u-SecA and therefore, comparison of the cross-linked
chymotryptic fragments was difficult. We developed a strategy (Figure 3.3, A (1-5)) that
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enabled us to cross-link signal peptide to c-SecA and digest this cross-linked product in
the same manner as u-SecA. One-dimensional SDS-PAGE revealed that the digestion
pattern was identical but as demonstrated in MS experiments in Chapter 2, the
heterogeneous nature of the chymotryptic SecA fragments generates different proteolytic
fragments of the same size. This heterogeneous population made the antibody mapping
difficult to interpret that prompted us to used two-dimensional gels to resolve this
problem since the SecA proteolytic fragments of similar size have different isoelectric
points (Figure 3.3, A (5-10)). This method helped us identify the SecA domains that were
cross-linked to signal peptide. Unfortunately, MS experiments to identify the residues in
SecA cross-linked to signal peptide were unsuccessful. Due to the high specificity of BP,
the cross-linking efficiency is low, in our case less than 10%. We tried to purify the
cross-linked SecA products using a monomeric streptavidin column but the presence of
urea decreased biotin affinity for the column and therefore, cross-linked u-SecA could
not purified. In the MS experiments several potential cross-linked SecA fragments were
identified but we were unsuccessful in obtaining sequence information by MS/MS. The
masses of the potential cross-linked fragments were mapped to the SecA sequence but
these fragments either did not contain a favorable cross-linking residue or the size of the
fragment was similar to two or more SecA proteolytic fragments. Thus, we relied on our
domain mapping strategy using region-specific antibodies to identify sites of crosslinking, which provided us a powerful method to determine the signal sequence-binding
site on c-SecA and the translocation-active u-SecA.

3.5.

Materials and Methods
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3.5.1. SecA titration Assay
C-SecA at 2.5 µM protein concentration in 20 mM HEPES pH 7.5, 50 mM KCl, 1
mM MgCl2, 1 mM DTT and u-SecA at 2.5 µM in 20 mM HEPES pH 7.5, 50 mM KCl, 1
mM MgCl2, 1 mM DTT, 2.2 M urea were generated by incubated at 22°C for four hours.
The biotinylated signal peptide, Bio-KRRLamB19C (BioMMITLRKRRKLPLAVAVAAGVCSAQAMA), was held constant at one µM while the
concentration of c-SecA and u-SecA from the previous equilibration step was titrated
from 0.1 µM to 2 µM in a reaction volume of 40 µl. The samples were equilibrated for
two hours at 22°C. After equilibration the samples were cross-linked by the addition of
gluteraldehyde to a final concentration of 0.1% and incubated at room temperature for
two minutes. Cross-linking reaction was quenched by the addition of 100 mM Tris pH
8.0 and each sample was run in duplicate on two different 6% tricine SDS-PAGE gels.
One gel was transferred to PVDF membrane while the other gel was stained with
Coomassie Blue or with SYPRO Ruby (BioRad).

3.5.2. Biotin detection
Membranes were blocked overnight at 4°C in 5% non-fat milk in phosphate
buffered saline with 0.1% tween-20 (PBS-T). The next day the membranes washed, and
probed with a streptavidin-HRP conjugate (GE Healthcare) at a 1:1000 dilution in PBS-T
for two hour at room temperature for gluteraldehyde cross-linking or overnight at 4°C for
1-D and 2-D gels. The cross-linked bands were detected using the SuperSignal West
Pico kit (Pierce, Rockford IL) following the manufacture’s instructions. The signal was
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visualized and recorded using a G:Box gel documentation unit (Syngene, Frederick,
MD).

3.5.3. Protein staining and visualization
Gels were stained with either Coomassie Blue or SYPRO ruby protein stain
(BioRad) overnight at room temperature with gentle shaking. The next day the gels were
destained according to the manufacture’s protocol. For visualization the SYPRO ruby dye
was excited with 254 nm light and recorded using a G:Box gel documentation unit
(Syngene, Frederick, MD). Coomassie Blue stain was recording using white light in the
G:Box gel documentation unit.

3.5.4. Biotin signal quantification and normalization
The signal from the biotin detection was quantified using ImageJ software
(http://rsb.info.nih.gov/ij/docs/index.html) (Abramoff et al., 2004). The images were
background subtracted and inverted so that the background was black and the fragments
were gray/white. The rectangle tool was used to measure the area and the mean-gray
value (pixels) in the cross-linked protein band (the size of the rectangle depended on the
size of the band). For each measured band a corresponding rectangle of the same area
was taken of the local background. The ImageJ software output is the area, the mean-gray
value, and the absolute intensity (AI), which is calculated by the program as a product of
the area times and mean-gray value. The relative intensity of each band was calculated by
dividing the corrected absolute intensity by the absolute intensity of one µM BioKRRLamB19C cross-linked to one µM SecA. The data was normalized for protein
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concentration by quantification of the SYPRO Ruby stained or Coomassie Blue stained
gel following a similar procedure outline above for biotin quantification.

3.5.5. Signal peptide competition assay
One µM of both c-SecA and u-SecA (in the buffers described above) were
incubated at 22°C for four hours. Bio-KRRLamB19C signal peptide at one µM was
added to both c-SecA and u-SecA and incubated at 22°C for 15 min. The samples were
added to tubes containing KRRLamB WT signal peptide
(MMITLRKRRKLPLAVAVAAGVMSAQAMA) from 0 – 20 µM. c-SecA was
incubated with the non-biotinylated signal peptide for one min before addition of 0.1%
gluteraldehyde. Cross-linking occurred at room temperature for two minutes before
quenching with 100 mM Tris pH 8.0. In the case of u-SecA, the samples were incubated
with the non-biotinylated signal peptide for one hour before cross-linking and quenching.
Each sample was run in duplicate on two different 6% tricine SDS-PAGE gels. One gel
was transferred to PVDF membrane while the other gel was stained with Coomassie
Blue. Quantification of the biotin bands was performed as described above and the data
were normalized for protein concentration from the Coomassie blue stained gels.

3.5.6. Labeling of signal peptide with maleimido-benzophenone
The Cys at position 19 of one mM Bio-KRRLamB19C signal peptide (GL
Biochem (Shanghai) Ltd) in 20 mM HEPES pH 7.5, 1.2 mM TCEP buffer was alkylated
by the addition of 1.5 mM 4-maleimido-benzophenone (MBP) (Sigma). The reaction was
stirred for 30 minutes at room temperature and the reaction was quenched by the addition
of TFA to lower the pH to ~2. The MBP-labeled peptide was purified by preparative RP148

HPLC using a phenyl (25x250 mm, 10 mm, 300 Å, Vydac) column using an appropriate
water/acetonitrile gradient. The purified MBP-labeled peptide was checked by analytical
RP-HPLC with a phenyl (4.6x150 mm, 5 mm, 300 Å, Vydac) column using an
appropriate water/acetonitrile gradient demonstrating that the purity of the MBP-labeled
peptide was greater than 95%. The identity and purity of the peptide was confirmed by
mass spectrometry analysis using an Esquire-LC Ion trap mass spectrometer (Bruker
Daltonics, Billerica, MA).

3.5.7. BPM cross-linking experiments
In order to determine if there are differences in the signal peptide binding region
between c-SecA and u-SecA, Bio-KRRLamB19C-MBP signal peptide was cross-linked
to both forms. In the absence of light, 2.5 µM Bio-KRRLamB19-MBP was added to 2.5
µM c-SecA in cross-linking buffer (20 mM HEPES pH 7.5, 50 mM KCl, 1 mM MgCl2, 1
mM DTT) and incubated for 15 min at room temperature to allow for complex formation.
The sample was then illuminated with 365 nm light at ~5 cm distance for one minute to
induce cross-linking. To obtain a chymotrypsin digestion pattern similar to u-SecA, urea
was added to the cross-linked c-SecA sample to a final concentration of 2.2 M and
incubated at 22°C for four hours. Prior to cross-linking, u-SecA was generated by
incubation of 2.5 µM of SecA in 2.2 M urea cross-linking buffer for four hours at 22°C.
Cross-linking of u-SecA was performed as described above followed by the addition of
2.2 M urea buffer to obtain the same final volume as the c-SecA sample.

3.5.8. Protease digestion and TCA precipitation
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Samples were digested with chymotrypsin (1:150 w/w) at room temperature for
either a time course of 10 sec to 10 min for 1-D gel analysis or for two minutes for 2-D
gel analysis. Digestion was quenched by the addition of 5 mM of the protease inhibitor
ABESF. For 2-D gels an aliquot of each sample was taken, run on an 8% tricine SDSPAGE gel, and stained with Coomassie Blue to ensure proper digestion. The samples
were precipitated by the addition of one volume 100% trichloroacetic acid (TCA) to four
volumes of sample and then incubated overnight at -20°C. The precipitated proteins were
pelleted by a spin at 15,800 x g in a microcentrifuge. The pellet was washed with cold
acetone two times and dried at 95°C for 10 minutes. The dried protein pellets were
resuspended in 3X SDS-PAGE buffer for 1-D gel analysis or in rehydration buffer for 2D gel analysis.

3.5.9. 1-D gels
After resuspension in the 3X SDS-PAGE buffer, the TCA precipitated samples
were boiled in a water bath for five minutes. Each sample was run in duplicate on two
different 6% tricine SDS-PAGE gels. One gel was transferred to PVDF membrane while
the other gel was stained with Coomassie Blue. The membranes were probed
streptavidin-HRP, as described above, and the different region-specific SecA antibodies
as described in the previous chapter.

3.5.10. 2-D gels
TCA pellets for both c-SecA and u-SecA were resuspended in rehydration buffer
(8 M urea, 2% CHAPS, 0.4% Biolytes). Isoelectric focusing (IEF) strips (7 cm) pH range
4-7 were rehydrated with c-SecA and u-SecA samples according to manufacture’s
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protocol (Method 1 Passive rehydration, BioRad) and incubated at room temperature for
14-16 hours. The strips were focused using a linear voltage gradient according to the
manufacture’s program (BioRad). After focusing the strips were frozen at -80°C until
further use.
Prior to running the second dimension, the strips were thawed at room
temperature for 10 min. The strips were incubated in equilibration buffer I (6 M urea,
0.375 M Tris pH 8.8, 2% SDS, 20% glycerol, 2% (w/v) DTT) for 10 minutes at room
temperature followed by incubation in equilibration buffer II (6 M urea, 0.375 M Tris pH
8.8, 2% SDS, 20% glycerol, 2.5% (w/v) iodacetamide) for 10 minutes. The polymerizing
stacking gel was added to the top of an 8% Tricine SDS-PAGE gel and the strips were
slide into the polymerizing gel to ensure complete contact between the IEF strips and the
SDS-PAGE gel. A small well was created in order to run the non-IEF sample for
comparison to the IEF sample. After separation by SDS-PAGE, the gels were transferred
to PVDF membrane and probed with streptavidin-HRP, as described above, and the
different region-specific SecA antibodies as described in the previous chapter.

3.5.11. 2-D gel data analysis
To compare the cross-linking pattern between c-SecA and u-SecA, the Biotin
detection of both proteins was analyzed using Flicker program
(http://open2dprot.sourceforge.net/Flicker/) (Lemkin et al., 2005). Due to various
distortions and other variations between the two samples, the Flicker program morphs
and aligns two different images. In brief, three SecA fragments that are similar in both
images were selected as landmarks. These landmarks were used to affine warp the
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images resulting in the alignment of these landmarks. Flickering, which allows for rapid
flickering between the two overlaid images was enabled and similar and different crosslinked fragments in c-SecA and u-SecA were visualized.
The SecA proteolytic fragments from the biotin detection were manually picked
and analyzed using the ImageJ software (Abramoff et al., 2004). Fragments that have a
molecular weight lower than 50 kD were analyzed as described earlier except the circle
tool was used to define the fragment. Two criteria were used to define a fragment. The
biotin signal intensity must have fit completely inside the area of a circle with a minimum
radius of 5.0 pixels and a maximum radius of 10.5 pixels. This definition was used to
eliminate small background speckles from the chemiluminescence as well as streaks of
unfocused protein. The second criteria was that the mean-gray value of the fragment must
be two times greater than the mean-gray value of the local background. Once a fragment
has been defined, the AI of the local background was subtracted from the AI of the
fragment. Finally, the relative intensity of each fragment was calculated by normalizing
the data to the free signal peptide signal at the bottom of the gel. The average relative
intensity of each fragment was determined by take three different measurements of the
fragment using circles of different radii. If any of the mean-gray values of the fragments
were not two times higher than the local background signal the fragment was eliminated
from further analysis.
The different region-specific antibodies were used to identify the cross-linked
fragments. The Flicker program was used to align and identify the cross-linked fragments
(biotin detection) with the corresponding antibody detection. Since the same membrane
was used for all of the detections, the full-length SecA protein from the non-IEF sample
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(left side of the gel) was used to align the different images. Once the images were
aligned, flickering between the biotin image and antibody image was enabled which
allowed for the identification of the cross-linked fragments. Any fragment that was not
identified by the antibodies was eliminated.
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CHAPTER 4
SIGNIFICANT FINDINGS AND FUTURE DIRECTIONS

4.1.

Significant findings
The translocation of preproteins across membranes is an essential step in the

secretory pathway in all organisms. The bacterial secretory system requires three
components to accomplish the translocation process: the signal sequence, SecA, and the
membrane-embedded translocon. Although a significant amount of work has been
performed on each of these components, the molecular details of the interaction between
the signal sequence, SecA, the SecYEG translocon is still poorly defined. In this study,
we were able to define a signal sequence-binding site on the cytosolic and the
translocation-active conformations of SecA. Our work showed that both conformations
share the same binding site but this site is likely expanded in the activated form.
Our work demonstrated that the translocation-active form of SecA undergoes
dramatic domain dissociation. Dissociation of the C-terminal domains HWD, HSD, and
CLT creating the activated form of SecA is consistent with the highly active truncated
SecA64, which is missing the C-terminal one-third of the protein. Previous studies have
suggested that this C-terminal region of SecA is protease protected in translocation assys.
The dissociation of the PPXD and HWD is needed for the binding of SecA to the
SecYEG translocon as demonstrated by the recent crystal structure of truncated SecA
bound to the SecYEG translocon (Zimmer et al., 2008). The C-terminal domains, HWD,
C-terminal HSD, and CTL can form a 30 kD stable fragment upon protease digestion.
This fragment is similar to the membrane inserted portion of SecA previously described
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by Price et al. (Price et al., 1996). This observation suggests that the C-terminal domain
association with the membrane may help stimulate SecA’s translocation activity. When
SecA is pushed into the activated conformation, NBF I is also in a more proteolytic labile
conformation. This observation is consistent with the binding of NBF I to SecYEG
(Osborne and Rapoport, 2007) and that in our activated SecA NBF I is missing its
interaction partner and therefore, exists is a more molten globular state.
Although the exact interactions of full-length SecA with the translocon are still
poorly understood, we propose a model where NBF I, NBF II, and PPXD interact directly
with the SecY while the C-terminal one-third of SecA disengages from the rest of the
molecule and either interact with other components of the translocation system or the
phospholipids membrane. These interactions of the C-terminus cause it to adopt a
protease protected state while also releasing the suppression of the ATPase activity of
SecA.
We have identified a signal-sequence binding site on SecA that is similar to the
one proposed by Zimmer et al. (Zimmer et al., 2008) which is located at the interface
between NBF II, PPXD, and N-terminal HSD. This result is in conflict with previously
reported signal-sequence binding sites (see Chapter 3 Introduction for a full description
of the other binding sites). All of these results suggest three different possibilities: (1)
there are multiple signal-sequence binding sites on the cytosolic and actived forms of
SecA, (2) one site is the actually signal-sequence binding site and the other sites are
mature preprotein binding sites, and (3) all of the sites are mature preprotein binding
sites. Although there is evidence that SecA interacts directly with the signal sequence, it

155

is also possible that the ‘reading’ of the signal sequence is performed by the translocon
and not SecA.

4.2.

Future directions
The development of a soluble translocation-active form of SecA has been useful

in determining the conformational changes in the activated form of SecA as well as in
mapping the signal sequence-binding site. Several questions regarding the mechanistic
details of SecA translocation remain unanswered. How do the preprotein, SecA, and
translocon work together? How does the preprotein remain in an unfolded conformation
after release from SecB? Why does SecA interact with preproteins in the cytosolic and
translocon-bound forms? These issue are explored and discussed in the sections below.

4.2.1. Structure of translocation-active SecA bound to preprotein
The crystal structure of truncated SecA/SecYEG (Zimmer et al., 2008) and the
work presented in this study have provided details about the conformation of
translocation-active SecA and interactions with signal sequences but this does not
provide the entire picture for how these three molecules interact in-vivo. To further
understand the nature of the interactions between preprotein, SecA, and SecYEG, more
structural details are needed. Cryo-electron microscopy would be an excellent option to
capture the SecA machine working to translocate the preprotein across the membrane.
This kind of experiment would provide insight into the SecA mechanism and may also be
applicable to other translocation machines.
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4.2.2. Preprotein interactions after release from SecB
At the onset of the SecA translocation cycle, the molecular chaperone SecB is
released from the preprotein/SecA/SecYEG complex. An intriguing question is how is
the non-translocated portion of the preprotein maintained in an unfolded state. There
must exist a sort of competition between the folding and translocation of the preprotein.
Single-molecule studies using fluorescence could monitor the folding of the nontranslocated portion of preprotein during the translocation process. One possibility is that
the pushing of the preprotein through the translocon provides enough force to keep the
preprotein in the unfolded state. This question could also be addressed using by using
single molecule techniques.

4.2.3. SecA /protein interactions in the cytosol
One rather puzzling question is why do preproteins interact with SecA in the
cytosol since the productive nature of the interactions is for translocation. A recent study
by Eser and Ehrmann (Eser and Ehrmann, 2003) suggests that SecA might actually
function in a quality-control manner to assist cytosolic proteins to fold by excluding them
from the secretory pathway. The partitioning of SecA between the membrane and the
cytosol indicates SecA could indeed have duel roles yet SecA can also recognize
preproteins in the cytosol. Further studies using single-molecule fluorescence may be
able to aid in the understanding of how SecA is able to differentiate between a secretory
and a cytosolic protein. These kinds of studies could also provide insight into how other
chaperones discriminate between substrates.

157

BIBLIOGRAPHY
Abramoff, M. D., Magelhaes, P. J., and Ram, S. J. (2004). Image Processing with
ImageJ. Biophotonics International 11, 36-42.
Alder, N. N., and Johnson, A. E. (2004). Cotranslation membrane protein biogenesis at
the endoplasmic reticulum. J Biol Chem 279, 22787-22790.
Baud, C., Karamanou, S., Sianidis, G., Vrontou, E., Politou, A. S., and Economou, A.
(2002). Allosteric communication between signal peptides and the SecA protein
DEAD motor ATPase domain. J Biol Chem 277, 13724-13731.
Beck, K., Wu, L. F., Brunner, J., and Muller, M. (2000). Discrimination between SRPand SecA/SecB-dependent substrates involves selective recognition of nascent
chains by SRP and trigger factor. Embo J 19, 134-143.
Benach, J., Chou, Y. T., Fak, J. J., Itkin, A., Nicolae, D. D., Smith, P. C., Wittrock, G.,
Floyd, D. L., Golsaz, C. M., Gierasch, L. M., and Hunt, J. F. (2003).
Phospholipid-induced monomerization and signal-peptide-induced
oligomerization of SecA. J Biol Chem 278, 3628-3638.
Bernstein, H. D., Poritz, M. A., Strub, K., Hoben, P. J., Brenner, S., and Walter, P.
(1989). Model for signal sequence recognition from amino-acid sequence of 54K
subunit of signal recognition particle. Nature 340, 482-486.
Briggs, M. S., and Gierasch, L. M. (1986). Molecular mechanisms of protein secretion:
the role of the signal sequence. Adv Protein Chem 38, 109-180.
Briggs, M. S., Gierasch, L. M., Zlotnick, A., Lear, J. D., and DeGrado, W. F. (1985). In
vivo function and membrane binding properties are correlated for Escherichia coli
lamB signal peptides. Science 228, 1096-1099.
Cabelli, R. J., Dolan, K. M., Qian, L. P., and Oliver, D. B. (1991). Characterization of
membrane-associated and soluble states of SecA protein from wild-type and
SecA51(TS) mutant strains of Escherichia coli. J Biol Chem 266, 24420-24427.
Cambronne, E. D., and Roy, C. R. (2006). Recognition and delivery of effector proteins
into eukaryotic cells by bacterial secretion systems. Traffic 7, 929-939.
Chen, Y., Pan, X., Tang, Y., Quan, S., Tai, P. C., and Sui, S. F. (2008). Full-length
Escherichia coli SecA dimerizes in a closed conformation in solution as
determined by cryo-electron microscopy. J Biol Chem 283, 28783-28787.
Chou, Y. T. (2003) The characterization of SecA and its interactions with signal
sequences in the bacterial secretory pathway, PhD, University of Massachusetts
Amherst, Amherst, MA.
158

Chou, Y. T., and Gierasch, L. M. (2005). The conformation of a signal peptide bound by
Escherichia coli preprotein translocase SecA. J Biol Chem 280, 32753-32760.
Chou, Y. T., Swain, J. F., and Gierasch, L. M. (2002). Functionally significant mobile
regions of Escherichia coli SecA ATPase identified by NMR. J Biol Chem 277,
50985-50990.
Christie, P. J., Atmakuri, K., Krishnamoorthy, V., Jakubowski, S., and Cascales, E.
(2005). Biogenesis, architecture, and function of bacterial type IV secretion
systems. Annu Rev Microbiol 59, 451-485.
Clerico, E. M., Maki, J. L., and Gierasch, L. M. (2008). Use of synthetic signal sequences
to explore the protein export machinery. Biopolymers 90, 307-319.
Cleverley, R. M., and Gierasch, L. M. (2002). Mapping the signal sequence-binding site
on SRP reveals a significant role for the NG domain. J Biol Chem 277, 4676346768.
Collinson, I. (2005). The structure of the bacterial protein translocation complex
SecYEG. Biochem Soc Trans 33, 1225-1230.
Cooper, D. B., Smith, V. F., Crane, J. M., Roth, H. C., Lilly, A. A., and Randall, L. L.
(2008). SecA, the motor of the secretion machine, binds diverse partners on one
interactive surface. J Mol Biol 382, 74-87.
Danese, P. N., and Silhavy, T. J. (1998). Targeting and assembly of periplasmic and
outer-membrane proteins in Escherichia coli. Annu Rev Genet 32, 59-94.
de Keyzer, J., Regeling, A., and Driessen, A. J. (2007). Arginine 357 of SecY is needed
for SecA-dependent initiation of preprotein translocation. FEBS Lett 581, 18591864.
de Keyzer, J., van der Sluis, E. O., Spelbrink, R. E., Nijstad, N., de Kruijff, B., Nouwen,
N., van der Does, C., and Driessen, A. J. (2005). Covalently Dimerized SecA Is
Functional in Protein Translocation. J Biol Chem 280, 35255-35260.
Dempsey, B. R., Wrona, M., Moulin, J. M., Gloor, G. B., Jalilehvand, F., Lajoie, G.,
Shaw, G. S., and Shilton, B. H. (2004). Solution NMR structure and X-ray
absorption analysis of the C-terminal zinc-binding domain of the SecA ATPase.
Biochemistry 43, 9361-9371.
den Blaauwen, T., Fekkes, P., de Wit, J. G., Kuiper, W., and Driessen, A. J. (1996).
Domain interactions of the peripheral preprotein Translocase subunit SecA.
Biochemistry 35, 11994-12004.

159

Deuerling, E., and Bukau, B. (2004). Chaperone-assisted folding of newly synthesized
proteins in the cytosol. Crit Rev Biochem Mol Biol 39, 261-277.
Deuerling, E., Schulze-Specking, A., Tomoyasu, T., Mogk, A., and Bukau, B. (1999).
Trigger factor and DnaK cooperate in folding of newly synthesized proteins.
Nature 400, 693-696.
Ding, H., Hunt, J. F., Mukerji, I., and Oliver, D. (2003a). Bacillus subtilis SecA ATPase
exists as an antiparallel dimer in solution. Biochemistry 42, 8729-8738.
Ding, H., Mukerji, I., and Oliver, D. (2001). Lipid and signal peptide-induced
conformational changes within the C-domain of Escherichia coli SecA protein.
Biochemistry 40, 1835-1843.
Ding, H., Mukerji, I., and Oliver, D. (2003b). Nucleotide and phospholipid-dependent
control of PPXD and C-domain association for SecA ATPase. Biochemistry 42,
13468-13475.
Dorman, G., and Prestwich, G. D. (1994). Benzophenone photophores in biochemistry.
Biochemistry 33, 5661-5673.
Doyle, S. M., Braswell, E. H., and Teschke, C. M. (2000). SecA folds via a dimeric
intermediate. Biochemistry 39, 11667-11676.
Driessen, A. J., Manting, E. H., and van der Does, C. (2001). The structural basis of
protein targeting and translocation in bacteria. Nat Struct Biol 8, 492-498.
Driessen, A. J., and Nouwen, N. (2008). Protein translocation across the bacterial
cytoplasmic membrane. Annu Rev Biochem 77, 643-667.
Duong, F. (2003). Binding, activation and dissociation of the dimeric SecA ATPase at the
dimeric SecYEG translocase. Embo J 22, 4375-4384.
Economou, A., and Wickner, W. (1994). SecA promotes preprotein translocation by
undergoing ATP-driven cycles of membrane insertion and deinsertion. Cell 78,
835-843.
Eichler, J., Rinard, K., and Wickner, W. (1998). Endogenous SecA catalyzes preprotein
translocation at SecYEG. J Biol Chem 273, 21675-21681.
Emr, S. D., and Silhavy, T. J. (1980). Mutations affecting localization of an Escherichia
coli outer membrane protein, the bacteriophage lambda receptor. J Mol Biol 141,
63-90.
Emr, S. D., and Silhavy, T. J. (1983). Importance of secondary structure in the signal
sequence for protein secretion. Proc Natl Acad Sci U S A 80, 4599-4603.

160

Eser, M. and Ehrmann, M. (2003). SecA-dependent quality control of intracellular
protein localization. Proc Natl Acad Sci U S A 100, 13231-13234.
Fak, J. J., Itkin, A., Ciobanu, D. D., Lin, E. C., Song, X. J., Chou, Y. T., Gierasch, L. M.,
and Hunt, J. F. (2004). Nucleotide exchange from the high-affinity ATP-binding
site in SecA is the rate-limiting step in the ATPase cycle of the soluble enzyme
and occurs through a specialized conformational state. Biochemistry 43, 73077327.
Fikes, J. D., and Bassford, P. J., Jr. (1989). Novel secA alleles improve export of
maltose-binding protein synthesized with a defective signal peptide. J Bacteriol
171, 402-409.
Fortin, Y., Phoenix, P., and Drapeau, G. R. (1990). Mutations conferring resistance to
azide in Escherichia coli occur primarily in the secA gene. J Bacteriol 172, 66076610.
Gasteiger, E., Hoogland, C., Gattiker, A., Duvaud, S., Wilkins, M. R., Appel, R. D., and
Bairoch, A. (2005). Protein Identification and Analysis Tools on the ExPASy
Server. In The Proteomics Protocols Handbook, J. M. Walker, ed. (Totowa, NJ,
Humana Press), pp. 571-607.
Gelis, I., Bonvin, A. M., Keramisanou, D., Koukaki, M., Gouridis, G., Karamanou, S.,
Economou, A., and Kalodimos, C. G. (2007). Structural basis for signal-sequence
recognition by the translocase motor SecA as determined by NMR. Cell 131, 756769.
Gierasch, L. M. (1989). Signal Sequences. Biochemistry 28, 923-930.
Gierasch, L. M., Rockwell, A. L., Thompson, K. F., and Briggs, M. S. (1985).
Conformation-function relationships in hydrophobic peptides: interior turns and
signal sequences. Biopolymers 24, 117-135.
Hegde, R. S., and Bernstein, H. D. (2006). The surprising complexity of signal
sequences. Trends Biochem Sci 31, 563-571.
Hell, K., Neupert, W., and Stuart, R. A. (2001). Oxa1p acts as a general membrane
insertion machinery for proteins encoded by mitochondrial DNA. Embo J 20,
1281-1288.
Hikita, C., and Mizushima, S. (1992). The requirement of a positive charge at the amino
terminus can be compensated for by a longer central hydrophobic stretch in the
functioning of signal peptides. J Biol Chem 267, 12375-12379.

161

Hoffmann, A., Merz, F., Rutkowska, A., Zachmann-Brand, B., Deuerling, E., and Bukau,
B. (2006). Trigger factor forms a protective shield for nascent polypeptides at the
ribosome. J Biol Chem 281, 6539-6545.
Hoyt, D. W., and Gierasch, L. M. (1991a). A peptide corresponding to an exportdefective mutant OmpA signal sequence with asparagine in the hydrophobic core
is unable to insert into model membranes. J Biol Chem 266, 14406-14412.
Hoyt, D. W., and Gierasch, L. M. (1991b). Hydrophobic content and lipid interactions of
wild-type and mutant OmpA signal peptides correlate with their in vivo function.
Biochemistry 30, 10155-10163.
Hunt, J. F., Weinkauf, S., Henry, L., Fak, J. J., McNicholas, P., Oliver, D. B., and
Deisenhofer, J. (2002). Nucleotide control of interdomain interactions in the
conformational reaction cycle of SecA. Science 297, 2018-2026.
Izard, J. W., Rusch, S. L., and Kendall, D. A. (1996). The amino-terminal charge and
core region hydrophobicity interdependently contribute to the function of signal
sequences. J Biol Chem 271, 21579-21582.
Jilaveanu, L. B., Zito, C. R., and Oliver, D. (2005). Dimeric SecA is essential for protein
translocation. Proc Natl Acad Sci U S A 102, 7511-7516.
Kaczanowska, M., and Ryden-Aulin, M. (2007). Ribosome biogenesis and the translation
process in Escherichia coli. Microbiol Mol Biol Rev 71, 477-494.
Kandror, O., Sherman, M., Rhode, M., and Goldberg, A. L. (1995). Trigger factor is
involved in GroEL-dependent protein degradation in Escherichia coli and
promotes binding of GroEL to unfolded proteins. Embo J 14, 6021-6027.
Karamanou, S., Bariami, V., Papanikou, E., Kalodimos, C. G., and Economou, A. (2008).
Assembly of the translocase motor onto the preprotein-conducting channel. Mol
Microbiol 70, 311-322.
Karamanou, S., Vrontou, E., Sianidis, G., Baud, C., Roos, T., Kuhn, A., Politou, A. S.,
and Economou, A. (1999). A molecular switch in SecA protein couples ATP
hydrolysis to protein translocation. Mol Microbiol 34, 1133-1145.
Keil, B. (1992). Specificity of proteolysis (Berlin-Heidelberg-NewYork, SpringerVerlag).
Keramisanou, D., Biris, N., Gelis, I., Sianidis, G., Karamanou, S., Economou, A., and
Kalodimos, C. G. (2006). Disorder-order folding transitions underlie catalysis in
the helicase motor of SecA. Nat Struct Mol Biol 13, 594-602.

162

Kessler, F., and Schnell, D. J. (2006). The function and diversity of plastid protein import
pathways: a multilane GTPase highway into plastids. Traffic 7, 248-257.
Kimura, E., Akita, M., Matsuyama, S., and Mizushima, S. (1991). Determination of a
region in SecA that interacts with presecretory proteins in Escherichia coli. J Biol
Chem 266, 6600-6606.
Kleywegt, G. J., and Jones, T. A. (1994). Detection, delineation, measurement and
display of cavities in macromolecular structures. Acta Crystallogr D Biol
Crystallogr 50, 178-185.
Korolev, S., Hsieh, J., Gauss, G. H., Lohman, T. M., Waksman, G. (1997). Major domain
swiveling revealed by the crystal structures of complexes of E. coli Rep helicase
bound to single-stranded DNA and ADP. Cell 90, 635-647.
Kutik, S., Guiard, B., Meyer, H. E., Wiedemann, N., and Pfanner, N. (2007). Cooperation
of translocase complexes in mitochondrial protein import. J Cell Biol 179, 585591.
Lanzetta, P. A., Alvarez, L. J., Reinach, P. S., and Candia, O. A. (1979). An improved
assay for nanomole amounts of inorganic phosphate. Anal Biochem 100, 95-97.
Lee, P. A., Tullman-Ercek, D., and Georgiou, G. (2006). The bacterial twin-arginine
translocation pathway. Annu Rev Microbiol 60, 373-395.
Lemkin, P. F., Thornwall, G., and Evans, J. (2005). Comparing 2-D Electrophoretic Gels
Across Internet Databases. In The Protein ProtocolsHandbook, J. Walker, ed.
(Totowa, NJ, Humana Press Inc), pp. 279-305.
Lill, R., Dowhan, W., and Wickner, W. (1990). The ATPase activity of SecA is regulated
by acidic phospholipids, SecY, and the leader and mature domains of precursor
proteins. Cell 60, 271-280.
Lotz, M., Haase, W., Kuhlbrandt, W., and Collinson, I. (2008). Projection structure of
yidC: a conserved mediator of membrane protein assembly. J Mol Biol 375, 901907.
Luirink, J., von Heijne, G., Houben, E., and de Gier, J. W. (2005). Biogenesis of inner
membrane proteins in Escherichia coli. Annu Rev Microbiol 59, 329-355.
McKnight, C. J., Briggs, M. S., and Gierasch, L. M. (1989). Functional and nonfunctional
LamB signal sequences can be distinguished by their biophysical properties.
Journal of Biological Chemistry 264, 17293-17297.

163

McKnight, C. J., Stradley, S. J., Jones, J. D., and Gierasch, L. M. (1991). Conformational
and membrane-binding properties of a signal sequence are largely unaltered by its
adjacent mature region. Proc Natl Acad Sci U S A 88, 5799-5803.
Miller, A., Wang, L., and Kendall, D. A. (2002). SecB modulates the nucleotide-bound
state of SecA and stimulates ATPase activity. Biochemistry 41, 5325-5332.
Mitchell, C., and Oliver, D. (1993). Two distinct ATP-binding domains are needed to
promote protein export by Escherichia coli SecA ATPase. Mol Microbiol 10, 483497.
Mitra, K., Schaffitzel, C., Shaikh, T., Tama, F., Jenni, S., Brooks, C. L., 3rd, Ban, N., and
Frank, J. (2005). Structure of the E. coli protein-conducting channel bound to a
translating ribosome. Nature 438, 318-324.
Mori, H., and Ito, K. (2006a). Different modes of SecY-SecA interactions revealed by
site-directed in vivo photo-cross-linking. Proc Natl Acad Sci U S A 103, 1615916164.
Mori, H., and Ito, K. (2006b). The long alpha-helix of SecA is important for the ATPase
coupling of translocation. J Biol Chem 281, 36249-36256.
Muller, M., Ibrahimi, I., Chang, C. N., Walter, P., and Blobel, G. (1982). A bacterial
secretory protein requires signal recognition particle for translocation across
mammalian endoplasmic reticulum. J Biol Chem 257, 11860-11863.
Musial-Siwek, M., Rusch, S. L., and Kendall, D. A. (2005). Probing the Affinity of SecA
for Signal Peptide in Different Environments. Biochemistry 44, 13987-13996.
Musial-Siwek, M., Rusch, S. L., and Kendall, D. A. (2007). Selective Photoaffinity
Labeling Identifies the Signal Peptide Binding Domain on SecA. J Mol Biol 365,
637-648.
Natale, P., Bruser, T., and Driessen, A. J. (2008). Sec- and Tat-mediated protein secretion
across the bacterial cytoplasmic membrane--distinct translocases and
mechanisms. Biochim Biophys Acta 1778, 1735-1756.
Natale, P., den Blaauwen, T., van der Does, C., and Driessen, A. J. (2005).
Conformational state of the SecYEG-bound SecA probed by single tryptophan
fluorescence spectroscopy. Biochemistry 44, 6426-6432.
Norby, J. G. (1988). Coupled assay of Na+,K+-ATPase activity. Methods Enzymol 156,
116-119.

164

Oliver, D. B., and Beckwith, J. (1982). Regulation of a membrane component required
for protein secretion in Escherichia coli. Cell 30, 311-319.
Oliver, D. B., Cabelli, R. J., Dolan, K. M., and Jarosik, G. P. (1990). Azide-resistant
mutants of Escherichia coli alter the SecA protein, an azide-sensitive component
of the protein export machinery. Proc Natl Acad Sci U S A 87, 8227-8231.
Or, E., Boyd, D., Gon, S., Beckwith, J., and Rapoport, T. (2005). The bacterial ATPase
SecA functions as a monomer in protein translocation. J Biol Chem 280, 90979105.
Or, E., and Rapoport, T. (2007). Cross-linked SecA dimers are not functional in protein
translocation. FEBS Lett 581, 2616-2620.
Osborne, A. R., Clemons, W. M., Jr., and Rapoport, T. A. (2004). A large conformational
change of the translocation ATPase SecA. Proc Natl Acad Sci U S A 101, 1093710942.
Osborne, A. R., and Rapoport, T. A. (2007). Protein translocation is mediated by
oligomers of the SecY complex with one SecY copy forming the channel. Cell
129, 97-110.
Osborne, A. R., Rapoport, T. A., and van den Berg, B. (2005). Protein translocation by
the Sec61/SecY channel. Annu Rev Cell Dev Biol 21, 529-550.
Ott, C. M., and Lingappa, V. R. (2004). Signal sequences influence membrane integration
of the prion protein. Biochemistry 43, 11973-11982.
Papanikolau, Y., Papadovasilaki, M., Ravelli, R. B., McCarthy, A. A., Cusack, S.,
Economou, A., and Petratos, K. (2007). Structure of dimeric SecA, the
Escherichia coli preprotein translocase motor. J Mol Biol 366, 1545-1557.
Papanikou, E., Karamanou, S., Baud, C., Frank, M., Sianidis, G., Keramisanou, D.,
Kalodimos, C. G., Kuhn, A., and Economou, A. (2005). Identification of the
preprotein binding domain of SecA. J Biol Chem 280, 43209-43217.
Papanikou, E., Karamanou, S., Baud, C., Sianidis, G., Frank, M., and Economou, A.
(2004). Helicase Motif III in SecA is essential for coupling preprotein binding to
translocation ATPase. EMBO Rep 5, 807-811.
Papanikou, E., Karamanou, S., and Economou, A. (2007). Bacterial protein secretion
through the translocase nanomachine. Nat Rev Microbiol 5, 839-851.
Patel, C. N., Smith, V. F., and Randall, L. L. (2006). Characterization of three areas of
interactions stabilizing complexes between SecA and SecB, two proteins involved
in protein export. Protein Sci 15, 1379-1386.
165

Price, A., Economou, A., Duong, F., and Wickner, W. (1996). Separable ATPase and
membrane insertion domains of the SecA subunit of preprotein translocase. J Biol
Chem 271, 31580-31584.
Ramamurthy, V., and Oliver, D. (1997). Topology of the integral membrane form of
Escherichia coli SecA protein reveals multiple periplasmically exposed regions
and modulation by ATP binding. J Biol Chem 272, 23239-23246.
Rapoport, T. A. (2008). Protein transport across the endoplasmic reticulum membrane.
Febs J 275, 4471-4478.
Rizo, J., Blanco, F. J., Kobe, B., Bruch, M. D., and Gierasch, L. M. (1993).
Conformational behavior of Escherichia coli OmpA signal peptides in membrane
mimetic environments. Biochemistry 32, 4881-4894.
Robson, A., Booth, A. E., Gold, V. A., Clarke, A. R., and Collinson, I. (2007). A large
conformational change couples the ATP binding site of SecA to the SecY protein
channel. J Mol Biol 374, 965-976.
Rusch, S. L., and Kendall, D. A. (2007). Oligomeric states of the SecA and SecYEG core
components of the bacterial Sec translocon. Biochim Biophys Acta 1768, 5-12.
Saier, M. H., Jr. (2006). Protein secretion and membrane insertion systems in gramnegative bacteria. J Membr Biol 214, 75-90.
Samuelson, J. C., Chen, M., Jiang, F., Moller, I., Wiedmann, M., Kuhn, A., Phillips, G.
J., and Dalbey, R. E. (2000). YidC mediates membrane protein insertion in
bacteria. Nature 406, 637-641.
Schmidt, M., Ding, H., Ramamurthy, V., Mukerji, I., and Oliver, D. (2000). Nucleotide
binding activity of SecA homodimer is conformationally regulated by temperature
and altered by prlD and azi mutations. J Biol Chem 275, 15440-15448.
Schnell, D., and Hebert, D. (2003). Protein translocons: multifunctional mediators of
protein translocation across membranes. Cell 112, 491-505.
Schuck, P., Perugini, M. A., Gonzales, N. R., Howlett, G. J., and Schubert, D. (2002).
Size-distribution analysis of proteins by analytical ultracentrifugation: strategies
and application to model systems. Biophys J 82, 1096-1111.
Scotti, P. A., Urbanus, M. L., Brunner, J., de Gier, J. W., von Heijne, G., van der Does,
C., Driessen, A. J., Oudega, B., and Luirink, J. (2000). YidC, the Escherichia coli
homologue of mitochondrial Oxa1p, is a component of the Sec translocase. Embo
J 19, 542-549.

166

Sharma, V., Arockiasamy, A., Ronning, D. R., Savva, C. G., Holzenburg, A., Braunstein,
M., Jacobs, W. R., Jr., and Sacchettini, J. C. (2003). Crystal structure of
Mycobacterium tuberculosis SecA, a preprotein translocating ATPase. Proc Natl
Acad Sci U S A 100, 2243-2248.
Shin, J. Y., Kim, M., and Ahn, T. (2006). Effects of signal peptide and adenylate on the
oligomerization and membrane binding of soluble SecA. J Biochem Mol Biol 39,
319-328.
Snyders, S., Ramamurthy, V., and Oliver, D. (1997). Identification of a region of
interaction between Escherichia coli SecA and SecY proteins. J Biol Chem 272,
11302-11306.
Song, M., and Kim, H. (1997). Stability and solvent accessibility of SecA protein of
Escherichia coli. J Biochem (Tokyo) 122, 1010-1018.
Stenberg, F., von Heijne, G., and Daley, D. O. (2007). Assembly of the cytochrome bo3
complex. J Mol Biol 371, 765-773.
Talmadge, K., Stahl, S., and Gilbert, W. (1980). Eukaryotic signal sequence transports
insulin antigen in Escherichia coli. Proc Natl Acad Sci U S A 77, 3369-3373.
Triplett, T. L., Sgrignoli, A. R., Gao, F. B., Yang, Y. B., Tai, P. C., and Gierasch, L. M.
(2001). Functional signal peptides bind a soluble N-terminal fragment of SecA
and inhibit its ATPase activity. J Biol Chem 276, 19648-19655.
Tsukazaki, T., Mori, H., Fukai, S., Ishitani, R., Mori, T., Dohmae, N., Perederina, A.,
Sugita, Y., Vassylyev, D. G., Ito, K., and Nureki, O. (2008). Conformational
transition of Sec machinery inferred from bacterial SecYE structures. Nature 455,
988-991.
Ulbrandt, N. D., London, E., and Oliver, D. B. (1992). Deep penetration of a portion of
Escherichia coli SecA protein into model membranes is promoted by anionic
phospholipids and by partial unfolding. J Biol Chem 267, 15184-15192.
Ullers, R. S., Genevaux, P., and Luirink, J. (2007). Cotranslational Protein Targeting in
Escherichia coli. In Molecular Machines Involved in Protein Transport across
Cellular Membranes, R. E. Dalbey, C. M. Koehler, and F. Tamanoi, eds.
(Amsterdam: Boston: Heidelber: London: New York: Oxford: Paris: San Diego:
San Francisco: Singapore: Sydney: Tokyo:, Academic Press).
Van den Berg, B., Clemons, W. M., Jr., Collinson, I., Modis, Y., Hartmann, E., Harrison,
S. C., and Rapoport, T. A. (2004). X-ray structure of a protein-conducting
channel. Nature 427, 36-44.

167

van der Laan, M., Bechtluft, P., Kol, S., Nouwen, N., and Driessen, A. J. (2004). F1F0
ATP synthase subunit c is a substrate of the novel YidC pathway for membrane
protein biogenesis. J Cell Biol 165, 213-222.
van der Sluis, E. O., Nouwen, N., Koch, J., de Keyzer, J., van der Does, C., Tampe, R.,
and Driessen, A. J. (2006). Identification of two interaction sites in SecY that are
important for the functional interaction with SecA. J Mol Biol 361, 839-849.
van der Wolk, J. P., Boorsma, A., Knoche, M., Schafer, H. J., and Driessen, A. J. (1997).
The low-affinity ATP binding site of the Escherichia coli SecA dimer is localized
at the subunit interface. Biochemistry 36, 14924-14929.
van der Wolk, J. P., Klose, M., de Wit, J. G., den Blaauwen, T., Freudl, R., and Driessen,
A. J. (1995). Identification of the magnesium-binding domain of the high-affinity
ATP-binding site of the Bacillus subtilis and Escherichia coli SecA protein. J Biol
Chem 270, 18975-18982.
van Wely, K. H., Swaving, J., Freudl, R., and Driessen, A. J. (2001). Translocation of
proteins across the cell envelope of Gram-positive bacteria. FEMS Microbiol Rev
25, 437-454.
Vassylyev, D. G., Mori, H., Vassylyeva, M. N., Tsukazaki, T., Kimura, Y., Tahirov, T.
H., and Ito, K. (2006). Crystal structure of the translocation ATPase SecA from
Thermus thermophilus reveals a parallel, head-to-head dimer. J Mol Biol 364,
248-258.
Veenendaal, A. K., van der Does, C., and Driessen, A. J. (2004). The protein-conducting
channel SecYEG. Biochim Biophys Acta 1694, 81-95.
Velankar, S. S., Soultanas, P., Dillingham, M. S., Subramanya, H. S., Wigley, D. B.
(1999). Crystal structures of complexes of PcrA DNA helicase with a DNA
substrate indicate an inchworm mechanism. Cell 97, 75-84.
von Braun, S. S., and Schleiff, E. (2007). Movement of endosymbiotic organelles. Curr
Protein Pept Sci 8, 426-438.
von Heijne, G. (1985). Signal sequences. The limits of variation. J Mol Biol 184, 99-105.
von Heijne, G. (1990). The signal peptide. J Membr Biol 115, 195-201.
von Heijne, G. (1998). Life and death of a signal peptide. Nature 396, 111, 113.
Vrontou, E., and Economou, A. (2004). Structure and function of SecA, the preprotein
translocase nanomotor. Biochim Biophys Acta 1694, 67-80.

168

Vrontou, E., Karamanou, S., Baud, C., Sianidis, G., and Economou, A. (2004). Global
co-ordination of protein translocation by the SecA IRA1 switch. J Biol Chem 279,
22490-22497.
Wang, H., Na, B., Yang, H., and Tai, P. C. (2008). Additional in vitro and in vivo
evidence for SecA functioning as dimers in the membrane: dissociation into
monomers is not essential for protein translocation in Escherichia coli. J Bacteriol
190, 1413-1418.
Willard, L., Ranjan, A., Zhang, H., Monzavi, H., Boyko, R. F., Sykes, B. D., and
Wishart, D. S. (2003). VADAR: a web server for quantitative evaluation of
protein structure quality. Nucleic Acids Res 31, 3316-3319.
Wittelsberger, A., Thomas, B. E., Mierke, D. F., and Rosenblatt, M. (2006). Methionine
acts as a "magnet" in photoaffinity crosslinking experiments. FEBS Lett 580,
1872-1876.
Woodbury, R. L., Hardy, S. J., and Randall, L. L. (2002). Complex behavior in solution
of homodimeric SecA. Protein Sci 11, 875-882.
Xie, K., and Dalbey, R. E. (2008). Inserting proteins into the bacterial cytoplasmic
membrane using the Sec and YidC translocases. Nat Rev Microbiol 6, 234-244.
Zimmer, J., Li, W., and Rapoport, T. A. (2006). A novel dimer interface and
conformational changes revealed by an X-ray structure of B. subtilis SecA. J Mol
Biol 364, 259-265.
Zimmer, J., Nam, Y., and Rapoport, T. A. (2008). Structure of a complex of the ATPase
SecA and the protein-translocation channel. Nature 455, 936-943.
Zopf, D., Bernstein, H. D., and Walter, P. (1993). GTPase domain of the 54-kD subunit
of the mammalian signal recognition particle is required for protein translocation
but not for signal sequence binding. J Cell Biol 120, 1113-1121.

169

